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SUMMARY
The goal of this thesis is to develop generalizable machine learning models for early
prediction of physiological decomposition from multivariate and multiscale physiological
time series data. A combination of recent advances in machine learning and the increased
availability of more granular physiological time series data (due to increased adoption of
electronic medical records in US hospitals) has encouraged the development of more accu-
rate prediction models for the critically ill patients. One such physiological decomposition
prediction task we consider in our work is the early prediction of onset of sepsis. Sepsis
is a syndromic, life-threatening condition that arises when the body’s response to infection
injures its own internal organs. While there are effective protocols for treating sepsis (e.g.
administration of broad-spectrum antibiotics, Intravenous fluids, and vasopressors) once
it has been diagnosed, there still exists challenges in reliably identifying septic patients
early in their course. The purpose of this work is to explore the feasibility of utilizing low-
resolution electronic medical record data and high-resolution physiological time series data
to develop accurate prediction models for onset of sepsis in critically ill patients.
We first investigate the connection between heart rate (HR) and blood pressure (MAP)
time series - as captured through quantification of the structure of their corresponding net-
work representation - for early signs of sepsis. We show that the topological features ex-
tracted from these network representations in combination with commonly available EHR
features have a better predictive power compared to traditional (such as multiscale entropy)
indices that are used to capture physiological time series variability.
We then explore the utility of recurrent neural network models for accurate prediction
of onset of sepsis. We present a recurrent neural survival model called Deep Artificial In-
telligence Sepsis Expert (DeepAISE). DeepAISE automatically learns predictive features
related to higher-order interactions and temporal patterns among clinical risk factors that
maximize the data likelihood of observed time to septic events. DeepAISE has been in-
xxi
corporated into a clinical workflow, which provides real-time hourly sepsis risk scores.
Additionally, we focus on making DeepAISE predictions interpretable wherein relevance
scores (inspired from the concept of saliency maps for convolutional neural networks) are
used to determine the top contributing factors of the output risk score at every point of time
during patient’s ICU stay.
Finally, we introduce the Conformal Multidimensional Prediction of Sepsis Risk (COM-
POSER) model wherein the focus is on developing a generalizable model that accounts for
care-level and institution specific patterns in data generation. We combine ideas from ad-
versarial domain adaptation, representation learning and conformal prediction to develop
a model that can adapt well to new target populations (without the requirement of obtain-
ing gold-standard labels). We show the generalizability of COMPOSER on five different
patient cohorts comprising of data from three different academic medical centers and two
different levels of care (Intensive Care Unit and Emergency Department).
Sepsis survivors often suffer from high rates of readmission and many survivors of sep-
sis face life-long, debilitating sequelae as a result of the disease. The findings presented in
this thesis provide significant clinical evidence for a radical change to the sepsis treatment
paradigm that has real-time high-dimensional data analysis and model transparency at its
center. The techniques developed in this thesis are general, and can be extended to other




1.1 Need for developing prediction models for onset of sepsis
Sepsis is known to be one of the oldest and most elusive syndromes in medicine. It is as
a life-threatening organ dysfunction caused by a dysregulated host response to infection
[1]. The pathophysiology of sepsis suggests that an infection in human body triggers a
complex, variable, and prolonged host response wherein both proinflammatory (directed
at eliminating invading pathogens) and anitiinflammatory mechanisms contribute to clear-
ance of infection and tissue recovery as well as organ injury and secondary infections [2].
Additionally, the exaggerated inflammation results in impaired tissue oxygenation and as a
result of which organ damage occurs.
Sepsis is a major public health concern accounting for more than $20 billion (5.2%) of
total US hospital costs in 2011 [3]. It has also been estimated that the total inpatient ad-
mission sepsis cost for Medicare patients was $41.5 billion in 2018 [4]. Sepsis affects over
1 million patients in United States (US) alone, killing roughly a quarter of those affected
[5, 6]. Though the condition lacks the same public notoriety as other conditions like heart
attacks, 6% of all hospitalized patients in US carry a primary diagnosis of sepsis as com-
pared to 2.5% for the latter. When all hospital deaths are ultimately considered, nearly 35%
are attributable to sepsis [6]. This condition stands in stark contrast to heart attacks which
have a mortality rate of 2.7-9.6% and only cost the US $12 billion annually, roughly half of
the cost of sepsis [3]. Additionally, studies have shown that survivors of sepsis often suffer
from long-term physical, psychological, and cognitive disabilities with significant health
care and social implications [7].
Starting in 2004 the Surviving Sepsis Campaign (SSC), an international consortium of
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professional societies involved in critical care, began addressing the variations in clinical
treatment regimens for sepsis and septic shock (a more severe form of sepsis) through the
promulgation of evidence based practice guidelines called “sepsis care bundles” [8]. These
bundles consolidate the results of numerous investigations that have repeatedly demon-
strated improvement in sepsis outcomes after the timely administration of broad-spectrum
antibiotics, Intravenous (IV) fluids, and vasopressors when indicated [9, 10, 11, 12]. The
most recent recommendation from the SSC is a 1-hr bundle that in addition to obtaining
diagnostic tests like cultures and lactate levels, prescribes standard treatment with broad
spectrum antibiotics, IV fluid, and vasoactive drugs if necessary, all within an hour of a
sepsis diagnosis [13]; Although effective treatment guidelines for sepsis treatment exist,
identifying true cases of sepsis before they are clinically apparent is categorically one of
the most important needs for modern medicine to address.
A recent study from Seymour et al. [14] observed that for every hour that the admin-
istration of antibiotics were delayed in septic patients, the risk of mortality increased by
4-8%. The above point in addition to the aforementioned factors highlight the need for
early recognition of sepsis in hospitalized patients. Estimates suggest that if septic patients
admitted to US hospitals were identified and appropriately treated with life-saving antibi-
otics as soon as organ failure is detected, there would be fewer deaths, fewer hospital days,
and a reduction in hospital expenditures by about $1.5 billion [15]. The main focus of
this thesis is to utilize data that are commonly available in the Electronic Health Records
(EHRs) to develop machine learning models that can assist in early recognition of onset of
sepsis.
1.2 Defining onset time of sepsis
Consistently identifying the onset time for sepsis presents unique challenges because the
condition manifests as a constellation of signs and symptoms with significant variability in
presentation and timing. The Third International Consensus Definitions for Sepsis (Sepsis-
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3) guidelines have provided two primary criteria for making a formal diagnosis of sepsis:
(i) there must be a suspicion for infection (indicated by the administration of antibiotics for
at least 72 hours with the concomitant collection of cultures) (ii) there must be a two-point
increase in the SOFA (Sequential Organ Failure Assessment) score [16, 1]. These criteria
have associated time points and from these time points, sepsis (which we will henceforth
identify as tsepsis−3) can be consistently labeled (see Table 1.1 for a description of all the
timepoints used in our study). While the Sepsis-3 criterion is considered the current stan-
dard for labeling sepsis onset time, previous consensus criteria for sepsis (based on Sepsis-1
and Sepsis-2 definitions) [8, 17] remain in wide use. Additionally, there are other sepsis
criteria developed by the Center for Disease Control (CDC) and Center for Medicare and
Medicaid Services (CMS) for use in surveillance studies [18, 19].
In our work, we use the Sepsis-3 clinical criterion i.e. tsepsis−3 for labeling the onset
time of sepsis.
Table 1.1: Description of defined time points utilized in the study.
Time point Criteria
tsuspicion Clinical suspicion of infection identified as the earlier
timestamp of antibiotics and blood cultures within a
specified duration. (If antibiotics were given first, the
cultures must have been obtained within 24 hours. If
cultures were obtained first, then antibiotic must have
been subsequently ordered within 72 hours)
tSOFA The occurrence of end organ damage as identified by
a two-point deterioration in SOFA score within a 6-
hour period
tsepsis−3 The onset time of sepsis-3 is marked when both
tsuspicion and tSOFA have happened within close prox-
imity to each other. Specifically, tSOFA must occur
24 hours before tsuspicion or up to 12 hours after the
tsuspicion (tSOFA + 24 hours > tsuspicion > tSOFA - 12
hours). The earlier of the tSOFA or tsuspicion was as-
signed to tsepsis−3.
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1.3 Machine learning models for predicting onset of sepsis
In recent years, the increased adoption of Electronic Health Records (EHRs) in hospitals
has led to the emergence of Big data in healthcare [20]. The increased opportunities for
access to these big data, in parallel with advancements in machine learning has provided
an impetus to the development of machine learning based models to analyze these large
amounts of data. As a result of this, there has been increased interest to utilize machine
learning (ML) techniques in the area of early recognition of sepsis [21].
In this section, we will discuss some of the published works that focus on early pre-
diction of sepsis that are of relevance to this thesis. We direct the reader to the paper from
Fleuren et al. [21] for a more comprehensive analysis of all ML based sepsis predictions
models that have been published until 2019. The Physionet 2019 challenge focused on
development of algorithms for the early prediction of sepsis using routinely available clin-
ical data from three different hospitals in the US. A total of 104 groups from academia
and industry participated, submitting entries based on various deep learning approaches to
predict the onset of sepsis six hours in advance [22]. Desautels et al. [23, 24] used a pro-
prietary machine learning system called InSight based on commonly available patient data
(vitals, Oxygen saturation, Glasgow Coma Score and Age) to predict onset of sepsis (level
of care: ICU, Sepsis-3 criterion) four hours in advance with Area Under the Curve (AUC)
in the range of 0.78-0.85. Nemati et al. [25] used a modified Weibull-Cox model on a
combination of low-resolution Electronic Medical Record (EHR) data and high-resolution
vital signs time series data (a total of 65 features) to predict onset of sepsis (level of care:
ICU, Sepsis-3 criterion) four hours in advance with an AUC of 0.85. Futoma et al. [26]
proposed a multiple-output gaussian process based recurrent neural network model for clas-
sifying patient encounters (level of care: ICU, modified SIRS criterion) as being septic or
not. Lukaszewski et al. [27] demonstrated that a neural network using only cytokine data
predicted sepsis (level of care: ICU, Sepsis-1 criterion) better than a similar algorithm using
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clinical EMR data. However, cytokines are not routinely measured, making it an impracti-
cal tool for contemporary practice. Giannini et al. [28] used a random-forest classifier on a
total of 587 features (consisting of demographics, vital signs and laboratory results) to pre-
dict onset of sepsis (level of care: ICU, International Classification of Diseases 9th Edition
codes for severe sepsis) with an AUC of 0.88. Khojandi et al. [29] used a random-forest
classifier on a total of 57 features (vital signs and demographics) to classify patients to be
septic or not (level of care: All in patient admissions, SIRS criterion). Wyk et al. [30] used
a random-forest classifier on a dataset of high-frequency physiological signals to discrimi-
nate between septic and non-septic patients (level of care: ICU, Sepsis-2 criterion). Henry
et al. [31] used a Cox proportional hazards model to predict the onset of septic shock in
patients admitted to the ICU. Septic shock is a more severe form of sepsis, wherein sepsis
leads to low blood pressure that persists despite treatment with intravenous fluids. It should
be noted that a direct comparison of these methods is not possible for several reasons: 1)
utilization of different labels for sepsis and septic shock, 2) variations in prediction hori-
zon (finite prediction vs infinite horizon prediction), 3) differences in frequency of predic-
tion (single event classification vs sequential prediction), and 4) variations in study design,
disease prevalence (case-control design vs calibrated real-world prevalence models), and
evaluation methods (e.g., classification versus sequential prediction with varying window
sizes).
1.4 Limitations of predictive models in healthcare
Although there has been a growing body of literature on ML models for prediction of
sepsis, very few of these have been successfully integrated into a Clinical Decision Support
(CDS) system. There are various reasons for this including the lack of interoperability and
generalizability (across different institutions or across different levels of care within the
same institution) of these models, poor understanding of CDS requirements and bedside
workflow processes for a predictive model etc. The work presented in this thesis attempts
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to identify key problems in developing ML based generalizable models for predicting onset
of sepsis, and provides frameworks and solutions that may help with the deployment and
successful integration of these predictive models as a CDS system. In the following three
sections, we will briefly discuss and introduce the main focus areas of the thesis.
1.4.1 Capturing interactions in high resolution vital signs time series data
Much of the existing literature on application of predictive analytics to early prediction
of sepsis has focused around the EHR and lab results as features for a supervised ML
model. However, the resolution of EHR data is far too coarse to produce individually
specific predictions. In fact, often availability of certain lab results in themselves may be
indicative of clinical suspicion of sepsis. Conversely, without having a clinician in the loop
to recognize early signs of decompensation and order the necessary lab values, an EHR-
based predictive analytic algorithm may not have access to the required features to predict
sepsis in a timely manner. A possible solution to this caveat would be to build predictors
based on continuously measured high resolution data such as Heart Rate (HR) and Blood
Pressure (BP) time series. It has been studied that the time-series of HR and BP exhibit rich
dynamical patterns of interactions and coupling prior to onset of sepsis [32, 33]. According
to the anti-inflammatory reflex model [34], pathogen-induced inflammation increases the
activity of vagus nerve which controls the production of pro-inflammatory cytokines and
prevents tissue damage. Although, the relationship amongst inflammation, vagus nerve
activity and heart rate variability (HRV) and Baroreflex control of BP and HR is complex,
this model suggests that monitoring indices of heart rate variability and complexity (as
markers of vagus nerve activity) may provide useful surrogate markers of the inflammatory
reflexes in healthy and diseased populations.
In recent years, one of the novel advances in time series representation and quantifi-
cation has been the mapping of time series to network, based on ideas such as transition
probabilities [35, 36], visibility [37, 38], and correlations [39, 40]. Each of these studies
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demonstrated that many characteristics of time series can be extracted from the properties
of the corresponding network. Moreover, network-based representations are capable of ex-
tracting more nuanced characteristics of time series and could therefore help in building
accurate prediction models for onset of sepsis.
1.4.2 Interpretable predictive models in healthcare
While performance characteristics of machine learning algorithms are important, providing
interpretable data to the bedside clinicians that can guide diagnosis and therapeutic inter-
ventions is a critical requirement of CDS systems. A major barrier to wide adoption of
modern machine learning based CDS tools in clinical practise has been their “black box”
nature [41]. Thus, there has been increased focus on not only developing high accuracy
models but also ensuring that such models provide interpretable explanations of their pre-
dictions.
Traditional computational techniques such as logistic regression models and decision
trees are popular amongst researchers as they have explainability built into the model itself.
However, this should be treated with caution as these explanations represent a “global”
notion of interpretability wherein features that contribute to the outcome, for the cohort at
large are identified as the top contributing factors. It is often the case that the top contribut-
ing factors vary from patient to patient (i.e. local interpretability), and employing models
that provide globally important factors would serve limited purpose to the bedside clini-
cians. While delving into the analysis of top factors contributing to an outcome risk score,
there are two types of factors involved: 1) multiplicative interactions where the degree of
risk associated with a factor (e.g. temperature) is a function of other factors in a multiplica-
tive sense (e.g. hypothermia and old age are together a greater risk factor than either by
itself), 2) temporal contexts of a risk factor can alter its contribution to a given risk score
calculation (e.g. leukocytosis immediately after surgery may not be unexpected and con-
tribute differently to the risk for sepsis). These multiplicative and temporal factors result
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in variations in the importance of risk factors when viewed from a local, hourly prediction
perspective for each patient. Thus, there is a need to develop models which provide locally
interpretable predictions for each patient.
1.4.3 Generalizability of machine learning models in healthcare
With advances in tools for collecting and analyzing healthcare data, there have been an
increasing number of machine learning algorithms applied to CDS tasks. Sendak et al.
provide a comprehensive review of such algorithms, with an emphasis on models that have
been integrated into clinical workflow. In addition to the examples mentioned in Section
1.3, other examples of CDS systems include early prediction of AKI [42, 43], as well as
algorithms for ED triage [44], prediction of cardiac arrest [45], 30 days readmission predic-
tion [46], and inpatient fall risk assessment [47], among others. However, very few of these
CDS systems have been adopted into clinical practise and a prominent reason for this is due
to the fact that they suffer from lack of generalizability across institutions and performance
degradation within the same institution [48]. This lack of generalizability is due to number
factors including differences in local populations, EHR systems, coding definitions, labo-
ratory equipment and assays, as well as variations in clinical and administrative practices.
For instance, most existing published clinical ML and predictive analytics models are either
based on data from a single hospital [26, 31] or multiple hospitals from the same healthcare
system [49] where the processes of care are mostly standardized. Although less common,
clinical ML models that have been validated across different healthcare systems are either
re-trained from scratch or are fine-tuned (via transfer learning) on every new patient co-
hort [24, 25, 50], or when applied out-of-the-box often exhibit significant degradation in
performance [51]. It should be noted that re-training of models is typically expensive and
impractical (namely due to the difficulty of obtaining gold-standard labels).
As noted by Agniel et al. [52], while without careful considerations of context EHR
data may be unsuitable for answering many research questions, when healthcare processes
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are adequately addressed and incorporated into ML models through introduction of in-
ductive biases (i.e., necessary and appropriate assumptions built into model architecture,
learning process, and application/deployment) such data can be leveraged to gain insight
into patients’ state of health.
1.5 Document Outline and Thesis Contributions
In this thesis, we present techniques to analyse multivariate physiological time series for
prediction of early onset of sepsis:
• In Chapter 2, we focus on developing a technique to capture interactions between
multiscale HR and BP time series - through quantification of the structure of their
corresponding network representations - for early prediction of sepsis. The goal of
the predictive model is to define a set of physiological states that are represented
by the nodes of a network. Transitions among these physiological states are cap-
tured by the network edges, and the network structure thereby captures the state
trajectory through time. We utilize a non-parametric adaptive partitioning method
called Darbellay-Vajda partitioning algorithm to obtain state-space representation of
the HR-BP time series. We show that topological features extracted from these con-
structed networks in combination with commonly available EHR features have a bet-
ter predictive power compared to traditional indices (such as multiscale entropy) that
are used to capture physiological time series variability.
• Chapter 3 discusses DeepAISE (Deep Artificial Intelligence Sepsis Expert), a re-
current neural survival model for the early prediction of sepsis. DeepAISE utilizes:
1) a class of deep learning models called Recurrent neural networks (RNNs), and 2)
the Weibull Cox survival model on a combination of low-resolution EHR data and
high resolution vital signs time series data for early prediction of onset of sepsis.
This architecture was chosen in the context of predicting sepsis onset time as a time-
9
to-event analysis and considering that temporal changes in patients’ physiology are
important for prediction of sepsis. DeepAISE is an externally evaluated sepsis model
developed using over 25,000 patient admissions to the Intensive Care Units (ICUs) at
two Emory University hospitals, over 18,000 ICU admissions to the UC San Diego
Health system and over 40,000 ICU admissions from the Medical Information Mart
for Intensive Care-III (MIMIC-III) ICU database. This model has been incorporated
into a clinical workflow, which provides real-time hourly sepsis risk scores.
Furthermore, we focus on making DeepAISE predictions interpretable wherein we
propose to use relevance scores (inspired from the concept of saliency maps for con-
volutional neural networks) to determine the top contributing factors of the output
risk score at every point of time during an ICU stay. Additionally, the hidden repre-
sentations learned by the recurrent neural network are used to construct a lower di-
mensional view of a patients’ trajectory. These two attributes allow the bedside clin-
ician to identify pathologic deviations from expected physiology early and in real-
time throughout the duration of patients’ hospital admission. Moreover, we show that
the top causes can be broken down into two categories of positively and negatively
contributing factors to the risk score. Notably, this analysis has shed insight on the
input features contributing significantly to the sensitivity (positive contributors) and
specificity (negative contributors) of DeepAISE.
• With the goal of developing generalizable predictive models, Chapter 4 introduces
the Conformal Multidimensional Prediction of Sepsis Risk (COMPOSER) model.
We first propose a weighted input layer that is designed to handle missing data and
variations in data measurement frequency across various levels of care (Emergency
Departments, ICUs, Wards etc.) and across different institutions. We then utilize the
technique of Adversarial Domain adaptation to learn representations that minimize
healthcare system specific variations. A key importance of utilizing ADA training
procedure is the design of a predictive model that can adapt to new unlabeled tar-
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get patient population; therefore, gold-standard labels which are often expensive to
obtain, are not required to deploy the model at a new center. We finally utilize the
framework of conformal prediction for establishing the ’conditions for use’ of the
COMPOSER model. This enables one to explicitly determine at what level of data
covariance shift one may still trust a clinical risk score.
We show the generalizability of COMPOSER model by utilizing data from over
480,000 patients collected between 2016-2019 from three different academic medi-
cal centers in the US, including data from Emergency Departments (EDs), Intensive
Care Units (ICUs), and general wards. Additionally, the COMPOSER model pre-
dictions were validated against a cohort of 400 patients who were manually chart
reviewed to determine the onset of sepsis.
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CHAPTER 2
MULTISCALE NETWORK REPRESENTATION OF PHYSIOLOGICAL TIME
SERIES FOR EARLY PREDICTION OF SEPSIS
2.1 Introduction
Sepsis is known as a dysregulated immune-mediated host response to infection. Alteration
in heart rate (HR) and blood pressure (BP) variability and coupling prior to onset of sepsis
has been reported in the literature [32, 33], and potential links to neuro-immune system
interactions have been established. According to the anti-inflammatory reflex model [34],
pathogen-induced inflammation increases the activity of vagus nerve which controls the
production of pro-inflammatory cytokines and prevents tissue damage. Although, the rela-
tionship amongst inflammation, vagus nerve activity and heart rate variability (HRV) and
Baroreflex control of BP and HR is complex, this model suggests that monitoring indices
of heart rate variability and complexity (as markers of vagus nerve activity) may provide
useful surrogate markers of the inflammatory reflexes in health and disease.
Entropy is a measure of unpredictability of the state of a system, or equivalently, of
its average information content. Information can be thought of as a measure of “surprise”
and entropy can be thought of as a measure of “average surprise”. In recent years, one of
the novel advances in time series representation and quantification has been the mapping of
time series to network, based on ideas such as transition probabilities [35, 36], visibility [37,
38], and correlations [39, 40]. Each of these studies demonstrated that many characteristics
of time series can be extracted from the properties of the corresponding network. Moreover,
network-based representations are capable of extracting more nuanced characteristics of
time series.
In particular, the concept of modularity has been used to characterize time series [53].
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By modularity, we mean a set of densely connected nodes within a network. Other authors
have used the terms “cluster” or “communities” [54, 55, 56] to denote such constellation of
nodes. Networks with high modularity have dense connections between the nodes within
modules, but sparse connections between nodes in different modules. An interpretation of
what these modules represent is in terms of “set points” of a system. Classical physiology is
grounded on the principle of homeostasis in which regulatory mechanisms act to maintain
a steady state, i.e., “set point”. However, as argued by Ary Goldberger et al. in his editorial
[57], many physiological systems tend to operate out of equilibrium and in locally stable
regimes (several set points versus a single set point), hence the observation of modularity
in the resulting networks of joint HR and BP time series.
Therefore an aim of this study was to investigate the connection between HR and BP
time series structure, as captured through quantification of the structure of their correspond-
ing network representation, and early signs of sepsis. However, physiological time series
can often exhibit complex patterns of variability over multiple time scales [58, 59]. For
instance, time series of BP can exhibit oscillations on the order of seconds (e.g., due to the
variations in sympathovagal balance), to minutes (e.g., as a consequence of fever, blood
loss, or behavioral factors), to hours (e.g., due to humoral variations, sleep-wake cycle, or
circadian effects) [60, 61]. It should also be noted that interactions (or coupling) between
physiological systems are often caused by distinct physiological mechanisms that operate
across different time scales [62]. We therefore investigate the multiscale structure of vital
signs network and their utility for early prediction of sepsis.
2.2 A high resolution dataset of critically ill patients in the Intensive Care Unit
Heart rate (HR) and mean arterial blood pressure (MAP) time series at 2 seconds resolution
were collected from bedside monitors in an Emory affiliated Intensive Care Unit (ICU),
using the BedMaster system (Excel Medical Electronics, Jupiter FL, USA). All adult ICU
units were included in this study, including Medical and Surgical, Cardiac Care, and Neuro-
13
























































































































































Figure 2.1: Schematic diagram of the proposed algorithm. The DV partitions obtained
from the space of time-lagged HR and MAP time series are transformed to a network g
- which consists of a set of nodes and an Adjacency matrix. Every time scale will have a
corresponding network. Various topological attributes and features derived from the con-
structed networks are used as inputs to the SVM classifier. In addition to the network
attributes, EMR features are also fed into the SVM classifier
intensive care units. The bedside monitor data was then matched and time synchronized
to each patient’s EMR data. A total of 100 patients (around 22%) met the definition of
sepsis by Seymour et al. [16] at some time point during their ICU stay. The average
length of hospital stay (LOS) among the septic patients was 137.6 [68.2-295.7] hours, and
the percentages of in-hospital mortality and in-patient hospice were 15.2% and 13.5%,
respectively. The septic patients exhibited a higher average SOFA score compared to non-
septic patients (4.8 [3.1-6.8] versus 1.6 [0.6-3.4]).
2.3 Development of the multiscale network model
The goal in this work is to define a set of physiological states, that are represented by
the nodes of a network. Transition among these physiological states are captured by the
network edges, and therefore the network structure will capture the state trajectory through
time.
Dynamic Bayesian networks have been used to model the trajectory of the state of
physiological systems [63], where a system’s state refers to a set of (observed or latent) at-
tributes of the system that summarize all one needs to know about the system to predict its
evolution through time [64]. Parametric approaches such as the switching dynamical sys-
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tems [65] assume the states transition dynamics to follow a Markov Chain. The approach
taken in this work is non-parametric and we extract a set of system states via adaptive par-
titioning of the state-space. The partitions define the nodes in the corresponding network
representation of the time series, and the transition probabilities are captured by the edges.
2.3.1 Defining the state-space
Time-lagged embedding provides information on the underlying dynamical system without
having direct access to all the system variables [66]. As a first step to defining the state-
space we applied timed-lagged embedding (of order l) to each time series dimensions.
Next, the embedded time series samples were replaced by their rank orders (via rank order
transformation) to achieve robustness to outliers. This step exploited the fact that mutual
information between a set of random variables is invariant to invertible transformations
such as the rank order transformation. Next, we partitioned the resulting state-space using
an adaptive partitioning algorithm as described next.
2.3.2 The Darbellay-Vajda (DV) partitioning algorithm
As shown in Figure 2.1 the DV partitioning algorithm allows us to partition the state-space
associated with a multivariate time series into varying size bins (or hypercubes) for the
purpose of density estimation [67]. The DV partitioning was previously shown to be effec-
tive in calculating transfer entropy [68, 69], a statistical measure of the amount of directed
entropy transfer between two random processes, and it was shown to have lower computa-
tional cost than the competing methods. Similar to the method of variable-bandwidth kernel
density estimation [70], the DV partitioning algorithm automatically adjusts the bin (par-
tition) size, depending on the density and local distribution of the data points, but requires
no a priori assumption on the Kernel bandwidth and is computationally more efficient to
evaluate [68]. This is in contrast to the equipartitioning scheme (aka, a multidimensional
histogram) where the entire state-space is split into equal partitions, which is an inefficient
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method to represent non-uniformly distributed data (see Figure 2.2).
The DV partitioning algorithm involves recursively dividing the state-space into more
refined partitions, based on chi-squared test statistic that checks whether the data in the pro-
posed partitioned cells are uniformly distributed. Let us consider a bivariate (2-dimensional)
time series, X = [x1, x2, ...., xT ] and Y = [y1, y2, ....., yT ] where T is the length of the time
series. First, a non-linear transformation is applied to X and Y , wherein the data in each
time series are replaced by their rank orders (also called rank-order transformation). Let
the rank order transformed time series be denoted by U and V respectively. We perform
partitioning in the UV space as follows:
1. At every iteration, a bin (parent cell) is partitioned into smaller blocks (child cells)
and we use the chi-squared test of independence to decide on the need for partitioning
to child cells or not. The null hypothesis for the chi-squared test is that the sample
distribution in the parent cell is uniform.


















where, M is the total number of child cells for a parent cell, and Ni (i = 1, ....N) are
the sample numbers.
3. For a 5% significance level with 3 degrees of freedom, if S is greater than χ295%(3),
then the distribution of data is not uniform and partitioning is continued. If not, the
partitioning is stopped at that level. The level of statistical significance is a parameter
that can be tuned.
4. At first, the observation space is partitioned at the medians of U, V margins to gener-
ate 4 child cells. And the Chi-square test of independence is performed, if partition-
ing condition holds, the child cells are split into further smaller blocks (partitioned
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Figure 2.2: A two-dimensional visualization of DV partitioning. The observation space
consists of 1,000 data points sampled from a bivariate Gaussian distribution with σxy =
-0.9, σ2x = 1, and σ
2
y = 1. The figure shows the observation space after ordinal sampling.
It can be observed that densely populated regions in the space have smaller partitions, in
comparison to fewer partitions created in sparser areas.
at the medians of their respective margins), and this continues recursively until the
Chi-square test statistic is no more satisfied across all cells.
The output of the partitioning algorithm is thus a list of partitions P, with each partition
defined by a lower and upper bound in the observation space. An illustration of the DV
partitioning algorithm for bivariate data is shown in Figure 2.2 with the scatter plot of the
data and the corresponding partitions obtained. It should be noted that the aforementioned
procedure can be easily extended to any arbitrary N dimensional observation space.
2.3.3 Construction of network from partitions
Here we describe the process of construction of a network from a multivariate time series X.
An example of a multivariate time series would be the HR and MAP time series recorded
from a single subject. Given a list of partitions P , a map M : T ⇒ G can be defined
from the time domain T to the network domain G. More formally, let us define a map M










































































































































































































































































































































Scale 2 Scale 5
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Figure 2.3: Examples of networks constructed from bivariate time series (HR and
MAP) of a control (left panel) and a pre-septic (right panel) patient at different time
scales. Within each of the networks, the arrows represent the transition from one node to
another.
total number of time series recorded for each subject (in the above example, since HR and
MAP are recorded for every subject, k = 2), and Xi ∈ RL, with L being the length of
the time series, and g = {S,A} consisting of a set of nodes S and adjacency matrix A.
The total number of nodes N correspond to the total number of partitions obtained from
the DV partitioning algorithm. Therefore each partition pi (i = 1, ...N) is assigned to a
node ni ∈ N in the graph g. Every multidimensional data point in X is assigned to one
of the partitions. The adjacency matrix A is a NxN matrix where aij corresponds to the
transition from node ni to node nj . Two nodes ni and nj are connected in the network with
a weight aij , with aij representing the total number of transitions from node ni to nj . Each
partition pi can be thought of as a dynamical state in a physiological system and the aij of
the adjacency matrix represent the probability of transition between the dynamical states of
the system. In the above example, we would thus construct one network from the bivariate
time series (HR and MAP time series) recorded from the subject.
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Multiscale Network representation
Interactions in biological systems manifest on multiple time scales [62], and the interac-
tions may change in different ways at these different time scales. It may therefore be
important to capture this multiscale nature of the interactions to help differentiate between
healthy and unhealthy individuals. For a one dimensional time series [x1, x2, ...., xN ], a
coarse grained time series {y(τ)}, corresponding to the scale factor τ was constructed as fol-
lows: First, the original times series was divided into non-overlapping windows of length τ ;
second, the data points inside each window were averaged. In our experiments, we coarse
grained both HR and MAP according to the scale factor τ . Thus, for every scale factor τi
(i = 1, ...M), where M is the total number of scale factors, a network Gi (i = 1, ...M) was
constructed. Figure 2.3 provides a visualization of the networks constructed from bivariate
time series (HR and MAP) of a control and a pre-septic patient at different time scales.
2.3.4 Network attributes for classification
In our proposed algorithm, for the network that we obtain as described in the previous
sections, we compute many topological attributes and use the derived features for classifi-
cation. The following network attributes were computed for every network in the dataset:
number of nodes (total number of nodes in the network), number of edges (total number
of edges in the network), Link density (defined as the total number of edges divided by the
maximum possible edges in the network), average degree (the average value of the degree
of all nodes in the network, where the degree of a node is defined as the total number of
it’s neighboring edges), number of loops (the total number of independent loops in the
network, also know as the “cyclomatic number” or the number of edges that need to be
removed so that the network cannot have cycles), Loop3 (the total number of loops of size
3 in the network), Loop4 (the total number of loops of size 4 in the network), average
clustering coefficient (the clustering coefficient c(u) for node u can be defined as the ratio
of the number of actual edges between the neighbors of u to the number of possible edges
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between them, and the average clustering coefficient C(G) of a network is the average of
c(u) taken over all the nodes in the network), Pearson coefficient (the pearson correlation
coefficient for a degree sequence, also known as the assortativity coefficient [71]), Alge-
braic connectivity (the second smallest Eigen value of the Laplacian matrix of a network,
where the Laplacian matrix of a network is the difference between the sum of degrees of the
diagonal elements in adjacency matrix and the adjacency matrix), Closeness (the closeness
centrality, cc(u) for node u is the inverse of sum of distance from node u to all other nodes
in the network, where the closeness centrality of a graph is the average mean of the above is
the average of cc(u) taken over all the nodes in the network, Average eccentricity (eccen-
tricity of a node u is defined as e(u) = max{d(u, v) : v ∈ V }, where the distance d(u, v)
is the length of the shortest path from u to v, and V is the set of all nodes. The average ef-
fective eccentricity is the average of effective eccentricities over all nodes in the network),
Maximum effective eccentricity (Also known as the effective diameter, is defined as the
maximum value of effective eccentricity over all nodes in the graph), Spectral radius (de-
fined as the largest magnitude eigenvalue of the adjacency matrix of the network), Trace
(sum of the eigenvalues of the adjacency matrix, i.e.,
∑
λ, and Energy (squared sum of






2.3.5 Entropy and other EMR features
For every subject, their socio-demographics features (Age, Gender, Weight, Race) were
collected. We also included features that were commonly recorded by the bedside nurses
including, Mean Arterial Pressure (MAP ), Heart Rate (HR), Peripheral capillary Oxy-
gen Saturation (SpO2), Systolic Blood Pressure (SBP ), Diastolic Blood Pressure (DBP ),
Respiration Rate (Resp), Glasgow Coma Score (GCS), and Temperature (Temp). Each
of the above mentioned features were quantized into 8 levels, and each level was encoded
into dummy binary representations. And these discretized representations were used in the
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classification model. We also extracted a few features that capture history, comorbidity,
and the clinical context of the patient, including Charlson Comorbidity Index, Mechanical
Ventilation, Unit Information (surgical, cardiac care, or neuro-intensive care), as well as
Surgical Speciality (cardiovascular, neuro, ortho-spine, oncology, urology, etc) and Wound
Type (clean, contaminated, dirty, or infected) if the patient had a surgery in past 12 hours.
We also calculated the following features from the HR and MAP time series (2 second
resolution) derived from the bedside monitor’s proprietary software from the ECG and BP
waveforms: standard Deviation of HR (HRSTD), Standard Deviation of MAP (MAPSTD),
Multiscale Entropy [59] of (60/HR or RR intervals) and MAP (Over 17 Scales; RRMSE ,
and MAPMSE respectively)
2.4 Feature selection and classification
For every subject in the dataset, networks were constructed for time scales 1 through 10.
A total of 16 network attributes were extracted from every constructed network. It is to
be noted that the HR and MAP were each processed with a lag of order l. In addition to
the network attributes, the Entropy and EMR features as described in Section 2.3.5 were
extracted. All the features were then used to train a Support Vector Machine (SVM) clas-
sifier to predict onset of sepsis four hours ahead of time, based on the data from preceding
six hours. The output of the SVM was the probability of membership in the Sepsis class.
Hyper-parameters of the model including the time scale factors, and lag order l were opti-
mized using Bayesian Optimization technique [72].
For all continuous variables, we have reported the medians with Inter-Quartile range
(IQR), and utilized a two-sided Wilcoxon ranksum test when comparing the septic and
control populations. For binary features, we have reported the percentages, and utilized a
two-sided Chi-square test to assess differences in proportions between the septic and con-
trol populations. To assess the performance of the proposed algorithm on out-of-sample
data, we performed a 10 fold cross validation study. The features in training set were trans-
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Table 2.1: Patient characteristics in the dataset
Control Septic p-value
N 100 150 –
Age 59.5 [46.0 68.0] 63.0 [47.5 72.5] 0.15
Male(%) 56% 48% 0.21
MAP 81.7 [75.0 90.1] 78.5 [70.3 91.3] 0.22
HR 84.8 [73.2 97.6] 92.5 [75.1 110.0] <0.01
SpO2 97.6 [96.3 99.3] 97.9 [95.1 99.5] 0.32
SBP 126.0 [111.7 143.7] 121.2 [103.3 143.3] 0.20
DBP 60.0 [55.0 66.7] 58.3 [52.5 67.2] 0.25
Respiration Rate 16.8 [14.2 18.7] 16.2 [2.25 20.4] 0.3
GCS 14.5 [10.0 15.0] 9.7 [6.0 14.3] <0.01
formed to have Gaussian distributions using either the identity, square root or logarithmic
transformations. The transformation which provided the lowest k-statistic using the Lil-
liefors test was used on both training and test sets. The transformed data (both training and
test data) was then normalized by subtracting the mean computed from the training set and
dividing by the standard deviation computed from the training set. Feature transformation,
training, and classifier evaluation was performed separately for all the ten folds. Area Un-
der the Receiver Operating Characteristic (AUROC) curve, accuracy, and specificity were
calculated for training and test sets for all the folds. The sensitivity level was fixed at 0.85.
We combined all the predictions (probability of being septic) across all the 10 folds to
report a single pooled AUROC [73].
2.5 Results
A total of 250 subjects were considered for this study. The median [IQR] age for the septic
and control subjects was 63 [47.5 72.5] and 59.5 [46.0 68.0] respectively. The patient
characteristics of the entire dataset have been tabulated in Table 2.1. It can be observed
that the onset of sepsis is associated with a drop in MAP as well as SBP , DBP , and a
significant increase in HR (92.5 vs. 84.8) and a significant decrease GCS (9.7 vs. 14.5),
reflecting a moderate loss of consciousness or alertness.
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2.5.1 Construction of network based on HR and MAP
The most commonly selected scales and embedding dimension by the Bayesian Optimiza-
tion were scales 2, 3, 5, 6, 7, 9, and 10, lag order of 3. We therefore fixed these parameters
across all experiments and model comparisons. We employed feature selection to find
a minimum of set of relevant features. The most commonly selected features across all
scales included the average clustering coefficient, pearson correlation coefficient, spectral
radius, energy of graph, Trace, and number of loops of size 4.
In the following experiments we used the graph attributes alone as features for the
classifier. First, we constructed multiscale networks from HR alone, and the pooled testing
AUROC was 0.61. Next, we constructed multiscale networks from MAP alone, and the
pooled testing AUROC was 0.61. By combining HR and MAP, and constructing multiscale
networks achieved a pooled testing AUROC of 0.78.
2.5.2 Classifier trained on combination of Network, entropy and EMR features
Table 2.2: Performance summary of classifier trained on combinations of network, entropy
and EMR features. Values shown are pooled AUROCs
Model Training AUROC Testing AUROC
MSE 0.72 0.66
EMR 0.79 0.70
MSNR (MAP + HR) 0.85 0.78
MSE + EMR 0.83 0.73
MSNR + EMR 0.89 0.79
MSNR + MSE 0.85 0.75
MSNR + MSE + EMR 0.89 0.80
Seven separate models were constructed, based on, 1) multiscale entropy (MSE) fea-
tures calculated from the HR and MAP time series, 2) EMR features including patient
demographics, and other features described in Section 2.3.5, 3) features extracted from
Multiscale Network Representation (MSNR), 4) combining the EMR features and En-
tropy features (MSE + EMR), 5) combining MSNR and EMR features, 6) combining
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Figure 2.4: ROC curves for models based on combinations of network, entropy and
EMR features. For the model corresponding to MSNR + MSE + EMR features, the
AUROC on test set was 0.80, with a specificity of 0.57 at 0.85 sensitivity level. Notably,
MSNR features alone achieved an AUC of 0.78, with the corresponding sensitivity (0.85)
and specificity (0.56) marker on the plot
MSNR and MSE features, and 7) combining the EMR, MSNR and MSE features.
The performance of each of the above models have been tabulated in Table 2.2. The model
based on MSNR features alone achieved a pooled testing AUROC of 0.78, with a cor-
responding sensitivity of 0.85 and specificity of 0.56. Combining the MSE features and
MSNR features did not result in any improvement of AUROC (statistically insignificant).
Combining EMR features and the MSNR features resulted in an improvement in AUC
from 0.78 to 0.79 (statistically significant). For the model corresponding to MSNR +
MSE + EMR features, the pooled AUROC on test set was 0.80 (statistically significant),
with a specificity of 0.57 at 0.85 sensitivity level. The Receiver Operating Characteristic
(ROC) curves for the above models have been plotted in Figure 2.4.
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2.6 Discussion
We have shown that features derived from a multiscale HR and MAP time series network
provide approximately 20% improvement in the area under the receiver operating charac-
teristic (AUROC) for four hours ahead prediction of sepsis over traditional indices of heart
rate entropy. This improvement is attributable to the information embedded in the higher
order interaction of HR and MAP time series, as well as the proposed novel approach to
network construction that utilizes adaptive partitioning of the state-space to define a set of
discrete states. This discretization method naturally trades off uncertainty in defining an
event (a unique state) for a more accurate estimation of the probability of the event. The
resulting algorithm is quick to implement and readily extensible to multiscale analysis of
the time series networks. Our final model, which includes the most commonly available
clinical measurements in patients’ electronic medical record (EMR), multiscale entropy
features as well as the proposed network-based features, achieved an AUROC of 0.80 on
the testing set.
The proposed network construction technique takes advantage of the fact that the mu-
tual information between a set of random variables is invariant to invertible transformations
such as the rank order transformation (replacing the data by their ranks). The rank order
transformation makes the proposed technique robust to time series outliers samples with
high amplitudes. Moreover, time-lagged embedding provides information on the under-
lying dynamical system without having direct access to all the system variables [66]. By
applying the DV partitioning algorithm on the space of time-lagged embedded HR and
MAP time series we arrive at states that capture the nonlinear dynamics of HR and MAP.
Similar to the method of variable-bandwidth kernel density estimation [70], the DV parti-
tioning algorithm automatically adjusts the bin size (hypercubes), depending on the density
and local distribution of the data points, but requires no a priori assumption on the Kernel
bandwidth and is computationally more efficient to evaluate [68].
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Some of the most important features including the average clustering coefficient are
reflective of modularity of the network; networks with high modularity have dense connec-
tions between the nodes within modules but sparse connections between nodes in different
modules. In graph theory, a clustering coefficient is a measure of the degree to which nodes
in a graph tend to cluster together. Further study is needed to assess the correlation between
the network features considered in this work and other commonly used predictive features
within the literature. However, we hypothesize that the proposed framework provides a
more generalizable set of features that are highly descriptive of the break down in autoreg-
ulatory mechanisms, and predictive of the eventual physiological decompensations, as in
the case of sepsis. Notably, the multiscale nature of the proposed features provides robust-
ness to the varying durations and time-scales of physiological deterioration in critically
care patients.
Many methods have been proposed in the literature to study human physiology as a
complex network of interactions among body organs and processes. Much of the effort have
been concentrated on identification and quantification of the interactions between these
physiological processes [74]. Bashan et al. [75] proposed the concept of time delay stability
(TDS) to quantify the dynamic interactions among physiological processes, such as sleep
and cardio-respiratory coupling. Building upon the concept of TDS, interactions across
time scales and frequency bands have been explored to reveal dynamic interactions across
body organs [76, 77, 78]. Utilizing the concept of “information dynamics”, entropy-based
approaches have been proposed to quantify the information transfer between physiological
processes [79, 68]. Our proposed MSNR approach complements other pioneering works in
“Network Physiology“ by introducing a non-parametric approach to partitioning the state-
space, and taking advantage of network analysis to quantify the non-linear interactions
among multiple physiological time series.
Clinical decision support tools can help identify those at the highest risk for future sep-
sis. Although, the existing works on utilizing EMR and laboratory data for prediction of
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sepsis seem promising [27, 80, 23], they are limited by low-frequency, and often inconsis-
tent data collected for purposes other than timely and accurate representation of patients’
physiology. Highly predictive features extracted directly extracted from the high-resolution
vital signs time series can improve sepsis prediction over low-resolution clinical data in the
ICU patients, and a high-performance prediction model can be derived from a combination
of EMR and high-frequency physiologic data. A real-time system capable of early predic-
tion of sepsis, followed by appropriate antibiotics therapy, will have a significant impact on
the overall mortality and cost burden of this deadly disease [14].
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CHAPTER 3
DEEPAISE - AN END-TO-END DEVELOPMENT AND DEPLOYMENT OF A
RECURRENT NEURAL SURVIVAL MODEL FOR EARLY PREDICTION OF
SEPSIS
The part I of this chapter discusses DeepAISE (Deep Artificial Intelligence Sepsis Expert)
and presents results showing its performance on ICU cohorts from three different academic
medical centers in US. The part II of this chapter extends the analysis of DeepAISE to study
the interpretability of its predictions and its integration into clinical workflow.
3.1 PART I: Developing a sequential model architecture for early prediction of sepsis
In recent years, the increased adoption of electronic medical records (EHRs) in hospitals
has motivated the development of machine learning based surveillance tools for detection
or classification [26, 23, 81, 82, 27] and prediction [23, 25, 31] of patients with sepsis or
septic shock. For prediction of sepsis in particular, Desautels et al. [23] used a proprietary
machine learning algorithm called InSight to achieve an Area Under the Curve (AUC) of
0.78 in predicting onset of sepsis four hours in advance. Lukaszewski et al [27] demon-
strated that a neural network using only cytokine data predicted sepsis better than a similar
algorithm using clinical EMR data. However, cytokines are not routinely measured, mak-
ing it an impractical tool for contemporary practice. Nemati et al. [25] used a modified
Weibull-Cox model on a combination of low-resolution Electronic Medical Record (EHR)
data and high-resolution vital signs time series data to predict onset of sepsis four hours in
advance with an AUC of 0.85. Additionally, Futoma et al. [26] proposed a multiple-output
gaussian process based recurrent neural network models for classifying patient encounters
as being septic or not. Other works have focused on developing models to predict septic
shock, which occurs when sepsis leads to low blood pressure that persists despite treat-
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ment with intravenous fluids. In particular, Henry et al. [31] used the cox proportional
hazards model to predict the onset of septic shock in patients admitted to the ICU. They
developed their model based on the publicly available MIMIC-II clinical database. A direct
comparison of these methods is not possible for several reasons: 1) utilization of different
labels for sepsis and septic shock, 2) variations in prediction horizon (finite horizon predic-
tion vs infinite horizon prediction, 3) differences in frequency of prediction (single event
classification vs sequential prediction), and 4) variations in study design and disease preva-
lence (case-control design vs calibrated real-world prevalence models). To date most sepsis
prediction research has failed to make the transition into viable Clinical Decision Support
(CDS) systems owing to the relatively low clinical tolerance for false-alarms [83], as well
as the interpretability and workflow integration requirements for CDS systems [84, 85].
False clinical alarms not only increase the cognitive load on clinicians but can also expose
patients to unnecessary antibiotics and may contribute to emergence of antibiotic resistance
pathogens [86]. Nevertheless, identifying and treating true cases of sepsis before they are
clinically apparent is categorically one of the most important needs for modern medicine
to address.
The primary contribution of this work is a deep learning framework for prediction of
sepsis (called DeepAISE) that reduces incidents of false alarms by automatically learning
predictive features related to higher-order interactions and temporal patterns among clinical
risk factors for sepsis. Unlike comparable models, this algorithm maintains interpretability
by tracking the top relevant features contributing to the sepsis score as a function of time,
providing clinicians with rationale for alerts. Most importantly, DeepAISE is an externally
evaluated sepsis model developed using over 25,000 patient admissions to the Intensive
Care Units (ICUs) at two Emory University hospitals, over 18,000 ICU admissions to the
UC San Diego Health system and over 40,000 ICU admissions from the Medical Informa-
tion Mart for Intensive Care-III (MIMIC-III) ICU database.
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3.1.1 A multicenter dataset of critically ill patients in the ICU
We performed a retrospective study of all patients admitted to the ICUs at two hospitals
within the Emory Healthcare system in Atlanta, Georgia from 2014 to 2018. This inves-
tigation was conducted according to Emory University Institutional Review Board (IRB)
approved protocol #33069 and the UCSD IRB approved protocol #191098X. External eval-
uation of the DeepAISE algorithm was performed on two separate cohorts: 1) the UCSD
cohort, which consisted of all patients admitted to the ICUs at two hospitals within the UC
San Diego Health system in San Diego, California from 2016 to 2019, and 2) the Med-
ical Information Mart for Intensive Care-III (MIMIC-III) ICU database [87], which is a
publicly available database containing de-identified clinical data of patients admitted to the
Beth Israel Deaconess Medical Center in Boston, Massachusetts from June 2001 to October
2012. Patients 18 years or older were followed throughout their ICU stay until discharge or
development of sepsis, according to Sepsis-3 guidelines [1, 16]. During the external eval-
uation step, the DeepAISE model (trained on the Emory cohort) was fine-tuned and tested
on the UCSD and MIMIC-III cohorts separately, and a comparison with baseline models
was performed.
For the Emory cohort, data from the EHR (Cerner, Kansas City, MO) were extracted
through a clinical data warehouse (MicroStrategy, Tysons Corner, VA). High-resolution
heart rate and Mean arterial pressure time series at 2 seconds resolution were collected
from select ICUs, through the BedMaster system (Excel Medical Electronics, Jupiter, FL),
which is a third-party software connected to the hospital’s General Electric monitors for
the purpose of electronic data extraction and storage of high-resolution waveforms. Pa-
tients were excluded if they developed sepsis within or prior to the first 4 hours of ICU
admission (by analyzing pre-ICU IV antibiotic administration and culture acquisition) or if
their length of ICU stay was less than 8 hours or more than 20 days.
The Emory cohort contained a total of 25,820 patients, 1,445 of whom met the Sepsis-3
criterion four hours or later after ICU admission. Out of the 25,820 patients, 70% of them
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were used for developing the model (training set), 10% were used for hyper-parameter
optimization, and the remaining 20% formed the testing set (see Table 3.1 for a description
of the various holdout datasets that have been used for analysis in this chapter). The Emory
training set contained a total of 18,074 patients out of which 1,003 patients met the Sepsis-
3 criterion, and the Emory testing set contained a total of 5,165 patients out of which 287
patients met the Sepsis-3 criterion during their stay in the ICU. Those who developed sepsis
tended to have a slightly higher percentage of male patients compared to non-septic patients
(55.2% vs. 53.2%) and had more comorbidities (Charlson Comorbidity Index [CCI] 3 vs.
2). Septic patients had longer median lengths of ICU stay (5.9 vs. 1.9 days), higher median
SOFA scores (5.0 vs. 1.7), and higher hospital mortality (15.2% vs. 3.5%). The median
[interquartile range (IQR)] time from ICU admission to tsepsis−3 in the Emory cohort was
24 [9, 63] hours. Similar patterns were observed for the UCSD cohort (Table 3.6) and the
MIMIC-III cohort (Table 3.7).
The UCSD cohort contained a total of 18,752 patients, 1073 of whom met the Sepsis-
3 criterion four hours or later after ICU admission. Out of the 18,752 patients, 80% of
them were used for developing the model (training set), and the remaining 20% formed the
testing set. The MIMIC-III cohort contained a total of 40,474 patients, 2276 of whom met
the Sepsis-3 criterion four hours or later after ICU admission. Out of the 40,474 patients,
80% of them were used for developing the model (training set), and the remaining 20%
form the testing set. The patient characteristics of Emory, UCSD and MIMIC-III cohorts
are tabulated in Tables 3.5, 3.6 and 3.7.
The complete set of patient features (65 in total, see Section 3.4) was grouped into three
categories: clinical features (e.g. heart rate, mean arterial pressure, etc.), laboratory test
results (e.g. hemoglobin, creatinine, etc.) and demographic/history/context features (e.g.
age, care unit type, etc.). Some of the clinical or laboratory features that were unavailable
in the UCSD and MIMIC-III cohorts were treated as ‘missing’ features during fine-tuning
of DeepAISE.
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Table 3.1: Description of the various datasets used in the analysis of DeepAISE
Dataset Description
Emory training 70% of patients from the entire Emory cohort
Emory testing 20% of patients from the entire Emory cohort
Emory hyperparameter optimization 10% of patients from the entire Emory cohort
Emory year-based training Patients in Emory cohort from the year 2014 through 2017
Emory year-based holdout Patients in Emory cohort from the year 2017 through 2018
MIMIC training 80% of patients from the entire MIMIC-III cohort
MIMIC testing 20% of patients from the entire MIMIC-III cohort
UCSD training 80% of patients from the entire UCSD cohort
UCSD testing 20% of patients from the entire UCSD cohort
3.1.2 Development of the DeepAISE model
DeepAISE began producing scores four hours after ICU admission, and was designed to
predict (on an hourly basis) the probability of onset of sepsis within the next four hours.
The two distinct characteristics of the model were: 1) utilization of a class of deep learn-
ing algorithms for multivariate time series data known as the Gated Recurrent Unit (GRU)
[88] that allowed for modeling the clinical trajectory of a patient over time, and 2) deploy-
ment of a parametric survival model called the Weibull Cox proportional hazards (WCPH)
[89], which cast the problem of sepsis prediction to a time-to-event prediction framework
and allows for handling of right censored outcomes [25], using features learned from the
underlying GRU model. The parametric survival model allowed for efficient end-to-end
learning of the GRU and the WCPH parameters using standard deep learning optimization
techniques.
For each patient admitted to the Intensive Care Unit (ICU), the goal of the proposed
DeepAISE model was to predict (at a regular interval of 1 hour) the probability of onset
of sepsis, using all data available for the patient up until the time of prediction. Figure 3.1
provides an overview of the proposed DeepAISE model.
The notations that are followed throughout the rest of the chapter is described as fol-
lows: For a total of N patients admitted to the ICU, we considered a dataset D = {Di}Ni=1
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Figure 3.1: Schematic diagram of the Deep Artificial Intelligence Sepsis Expert
(DeepAISE) model. The 65 features that are measure/computed every hour are fed se-
quentially into a 2 layer stacked GRU framework, the output from the stacked GRU layer
is then fed into a fully connected layer, and a modified Weibull Cox Proportional Hazards
Model (WCPH) is employed to compute the probability of occurrence of sepsis within
the proceeding m hours (denoted by Ft(m), with t = [1, 2, . . . T ]). In our work, we are
interested in the prediction of onset of sepsis 4 hours in advance.
with Di = { Xi, Ti, ei, Ti }. The length of time series for patient i is denoted by Ti. A total
of 65 features are measured/computed every hour for every patient in the ICU. The features
for patient i is represented by Xi = [xi1,xi2, . . . ,xiTi], where xit ∈ R65 is the feature vector
at time step t. The sepsis event indicator for patient i is denoted by ei = [ei1, ei2, . . . , eiTi ]
where at time step t, eit = 0 if onset of sepsis does not occur within the prediction horizon
otherwise eij = 1. Ti = [τi1, τi2, . . . , τiTi] represents the time to sepsis event for patient i.
We considered the prediction of onset of sepsis as a sequential prediction task in our
study. To achieve this, the proposed DeepAISE model, shown in Figure 3.1, employed a
combination of a 2 layer stacked Gated Recurrent Unit (GRU) framework and a modified
weibull-cox proportional hazards model (WCPH) to predict the onset of sepsis at a regular
interval of 1 hour.
Let us consider a sequence of data of length Ti belonging to patient i. At each timestep
t the stacked GRU model takes in as input, the feature vector xit and stores the temporal
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information within its hidden layers.
The GRU model used in our study is composed of 3 components at every timestep t: the
reset gate rt, the update gate zt, and the hidden layer ht. The hidden layer ht is computed
as follows :
zt = σ(Wzxt + Uzht−1 + bz)
rt = σ(Wrxt + Urht−1 + br)
h̃t = tanh(Whxt + rt  Uhht−1 + bh)
ht = zt  ht−1 + (1− zt) h̃t
(3.1)
where σ() is the logistic sigmoid function,  denotes element-wise multiplication (or
Hadamard product) and W{z,r,h}, U{z,r,h}, b{z,r,h} are the weight matrices and bias terms
associated with the calculation of update gate, reset gate, and hidden unit respectively. In
this formulation of the GRU, if the reset gate is close to 0 the intermediate hidden layer
h̃t will ignore the previous hidden state ht−1 and reset with the current input xt, essentially
allowing the hidden state to ignore any information that would be irrelevant later. The
update gate controls the extent of information carried over from the previous hidden state
ht−1 to the current hidden state ht. This behavior of the GRU helps the DeepAISE model
to remember long-term dependencies that are present in the sequential data, and aids the
model in identifying and capturing information that is only necessary for prediction of
onset of sepsis.
In our proposed DeepAISE model, we stack 2 layers of GRU on top of each other to
increase the representational power of the model. We represent the GRUs in the stacked




{z,r,h}} ∀ l = 1, 2. Correspondingly
r(l)t , z
(l)
t , and h
(l)
t would be the output of reset gate, update gate and the hidden state of the
GRU in layer l at timestep t.
The output h(2)t from the stacked GRU layer is then fed into a fully connected layer
before being fed into the modified Weibull-cox proportional hazards model, for predicting
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onset of sepsis in the proceeding m hours (where m = 2, 4, 6, 8, 10 or 12 hours). The
weibull-cox proportional hazards is a more robust parametric counterpart to the more fa-
miliar cox proportional hazards model [89] . The Weibull-Cox model defines the baseline
hazard function as H0(m|λ, ν) = (ν/λ)(m/λ)ν−1, where λ > 0 is a scale parameter and
ν > 0 is a shape parameter. For a patient i, the hazard function H(m) at time step t is then
defined as -
Hit(m|xit, θ, β, λ, ν) = H0(m|λ, ν) exp(βTf(xit)) (3.2)
where f() is the output from the fully connected layer in the deep learning pipeline, β is
a L dimensional weight vector (β ∈ RL), and θ = {G(1), G(2), Wfc, bfc}. Wfc and bfc
denote the weights and bias term of the fully connected layer respectively. The survival
function (i.e. probability of not getting sepsis in the proceeding m hours from current time
step t) is given by -
St(m|xit, θ, β, λ, ν) = exp(−Λ0(m) exp(βTf(xit)) (3.3)
where Λ0(m) = (m/λ)ν is the cumulative base hazard rate. The probability that onset of
sepsis occurs with the proceeding m hours is then given by Ft(m) = 1− St(m).
Learning model parameters
Given the dataset D, we would like to compute the posterior probability over the parame-
ters of the model which is defined as p(θ, β, λ, ν|D) ∝ p(D|θ, β, λ, ν)p(θ)p(β)p(λ)p(ν).
We assume that p(θ), p(β), p(λ) and p(ν) are constant, and therefore maximization of the
posterior probability is nothing but maximization of the likelihood of the data. The pa-
rameters of the proposed model is then learned through the maximum likelihood approach,
wherein the log likelihood of the data is maximized (or the negative log likelihood of the
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data is minimized). The data likelihood is given in Equation 3.4.











[H0(τit|λ, ν) exp(βTf(xit))]eit exp(−Λ0(τit) exp(βTf(xit))
(3.4)
where for patient i at time step t, xit ∈ R65 is the feature vector, eit is the sepsis event
indicator, and τit represents the time to sepsis event.
Further, the negative log-likelihood of data is then denoted by -
L(θ, β, λ, ν) = − 1
N
logP (D|θ, β, λ, ν) (3.5)
We then follow a mini-batch stochastic gradient descent approach to learn the optimal
parameters of the model, by minimizing L(θ, β, λ, ν). Intuitively, maximizing the data
likelihood (or minimizing the negative log-likelihood) will correspond to: 1) maximizing
the probability that sepsis does not occur before time τit and 2) maximizing the probability
of actual sepsis events, when the events are not censored (i.e. eit = 1).
3.1.3 Data processing, model evaluation and statistical analysis
First, features in the Emory training set were normalized by subtracting the mean and di-
viding by the standard deviation (both of which were computed on the Emory training
set). Next, all the remaining datasets were normalized using the mean and standard devi-
ation computed from the Emory training set. For handling missing data, we used a sim-
ple sample-and-hold approach in all the datasets. For all continuous variables, we have
reported median ([25th - 75th percentile]). For binary variables, we have reported percent-
ages. The area under receiver operating characteristic (AUC) curves statistics, specificity
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(1-false alarm rate) and accuracy at a fixed 85% sensitivity level were calculated to mea-
sure the performance of the models. We have reported the DeepAISE performance results
of four hours ahead prediction on the training and testing sets of the Emory cohort. External
evaluation of DeepAISE was performed on the UCSD and MIMIC-III cohorts separately.
During the external evaluation step, the DeepAISE model was fine-tuned on the training
set of each evaluation cohort and was evaluated on the corresponding test set. Additionally,
we have also reported the performance results for 2, 4, 6, 8, 10 and 12 hours ahead predic-
tion of onset of sepsis. Statistical comparison of all AUC curves was performed using the
method of DeLong et al [90].
3.1.4 Hyperparameter optimization
We trained each model for a total of 200 epochs using the Adam optimizer [91], with a
learning rate fixed at 1e-2. The mini-batch size was fixed at a total of 1,000 patients (90%
control patients, 10% septic patients), with data randomly sampled (with replacement) in
every epoch. To minimize overfitting and to improve the generalizability of the model,
L1-L2 regularization was used with L2 regularization parameter set to 1e-3 and L1 regu-
larization parameter set to 1e-5. Our final model had 2 GRU layers stacked on top of each
other with the size of hidden state being 100 per layer, followed by 1 fully connected layer
with the size of the hidden state being 100, and the output of which was fed into a modi-
fied Weibull-Cox proportional hazards model for prediction of onset of sepsis. All of the
hyper-parameters of the model: Number of GRU layers, the size of hidden state in each of
GRU layers, Number of fully connected layers, the size of hidden state in each of the fully
connected layers, learning rate, mini-batch size, L1 regularization parameter, and L2 regu-
larization parameter were optimized using Bayesian optimization [92]. All pre-processing




DeepAISE prediction performance for sepsis onset
The DeepAISE model was trained to predict the early onset of sepsis (tsepsis−3). DeepAISE
made hourly predictions, starting four hours after ICU admission, and considered a total of
65 features that were commonly available in the EHR. The Emory training and testing sets
contained a total of approximately 500,000 and 125,000 hourly prediction windows, re-
spectively. External evaluation of the DeepAISE algorithm was performed on two separate
cohorts: 1) the UCSD cohort, and 2) MIMIC-III cohort. During the external evaluation
step, the DeepAISE model (trained on the Emory cohort) was fine-tuned and tested on
the UCSD and MIMIC-III cohorts separately, and a comparison with baseline models was
performed.
Table 3.2: Summary of DeepAISE performance for prediction horizons of 4, 6 and
12 hours.
Performance metric 4 hours 6 hours 12 hours
testing(training) testing(training) testing(training)
Emory cohort
AUC∗ 0.90 (0.94) 0.89 (0.90) 0.88 (0.89)
Specificity 0.80 (0.89) 0.78 (0.84) 0.73 (0.78)
UCSD cohort+
AUC∗ 0.88 (0.90) 0.87 (0.89) 0.85 (0.86)
Specificity 0.77 (0.78) 0.74 (0.77) 0.68 (0.70)
MIMIC-III cohort#
AUC∗ 0.87 (0.90) 0.86 (0.87) 0.83 (0.86)
Specificity 0.75 (0.78) 0.72 (0.75) 0.69 (0.73)
* AUC = Aread Under the Curve; Sensitivity was fixed at 0.85
+ DeepAISE model (trained on Emory cohort) fine-tuned to the UCSD cohort
# DeepAISE model (trained on Emory cohort) fine-tuned to the MIMIC-III cohort
The DeepAISE model reliably predicted tsepsis−3 four hours in advance with an AUC
of 0.90 (specificity of 0.80 at sensitivity of 0.85) on the Emory testing set. Slightly lower
performances were observed for the UCSD and MIMIC testing sets, with the fine-tuned
models achieving an AUC of 0.88 and 0.87 respectively for predicting tsepsis−3 four hours
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in advance (see Table 3.2 for more details).
To assess the impact of changes in institutional practices and patient populations over
time (temporal validation) we performed an experiment in which a model trained on Emory
year-based training set (patients in Emory cohort from the year 2014 through 2017) was ap-
plied to a holdout test set collected from 2017 to 2018 (Emory year-based holdout set). The
DeepAISE model achieved an AUC of 0.88 (Specificity of 0.75 at sensitivity of 0.85) on
the Emory year-based holdout set (see Figure 3.2 for more details), which was comparable
to the model performance on external evaluation cohorts.
Figure 3.2: Performance of DeepAISE that was first trained on Emory year-based
training set (patients in Emory cohort from the year 2014 through 2017) and then
applied to a heldout test set collected from 2017 to 2018 (Emory year-based holdout
set).
DeepAISE performance against other baselines
The DeepAISE model is a composite model made of a class of Recurrent Neural Network
(RNN) models known as Gated Recurrent Units (GRUs) [88] that feeds into a Weibull Cox
Proportional Hazards (WCPH) model. This architecture was chosen in the context of pre-
dicting sepsis onset time as a time-to-event analysis and considering that temporal changes
in patients’ physiology are important for the early prediction of sepsis. We assessed the
utility of this model architecture by comparing performance of DeepAISE against three
different baseline models: 1) a Logistic Regression (LR) model, 2) a Weibull-Cox propor-
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tional hazards (WCPH) model, and 3) a Feedforward Neural Network (FFNN) with two
layers of 100 hidden units and a final WCPH layer for prediction of onset of sepsis (See
Figure 3.3). A more comprehensive comparison of DeepAISE with other baseline models
can be found in Figure 3.16.
Figure 3.3: Comparison of DeepAISE performance on Emory testing set for prediction
horizons of 2, 4, 6, 8, 10 and 12 hours.
Across all prediction windows, DeepAISE consistently outperformed all other baseline
classifiers (p < 0.001; when AUC of DeepAISE was compared with AUC of other baseline
methods) for prediction of tsepsis−3 (See Figure 3.3, Figure 3.16 and Table 3.4) and across
all prediction windows, indicating that capturing temporal trends and interactions among
the risk factors is important for accurate prediction of sepsis. The performance of all the
models decreased with the increase in prediction horizon. For DeepAISE, the AUC on the
Emory testing set decreased from 0.90 at 4-hour prediction horizon to 0.88 at 12-hour pre-
diction horizon. We also observed that these findings were consistent with the performance
of the fine-tuned model on the UCSD and MIMIC testing sets (Figure 3.4 and Figure 3.5).
In addition, a FFNN trained to predict tsepsis−3 with delta change in SOFA score as
input achieved 0.54 AUC on Emory testing set, and a FFNN trained to predict tsepsis−3
with delta change in SOFA score and static covariates (such as age, gender, weight etc.) as
inputs achieved 0.68 AUC on the Emory testing set. The above results show that DeepAISE
scores were not simply recapitulations of the SOFA scores.
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(a) (b)
* LR = Logistic Regression layer, FFNN = Feedforward Neural Network, WCPH = Weibull Cox Proportional
Hazard layer, FC = Fully Connected layer, AISE = Artificial Intelligence Sepsis Expert
Figure 3.4: Comparison of performance of baseline models and DeepAISE on the
UCSD cohort to predict tsepsis−3 for prediction horizons of 2, 4, 6, 8, 10, and 12 hours.
a) The Area Under the Curve (AUC) is shown in the left panel. b) The Specificity (SPC) is
shown in the right panel.
Performance of DeepAISE under different levels of missingness
We evaluated the performance of DeepAISE algorithm (when fine tuned to a new cohort)
under different levels of missingness of input features (specifically laboratory measure-
ments). For every patient, we computed the percentage of missing laboratory measure-
ments (the percentage of missing measurements was computed over a rolling 24 hour
window, and were then averaged across all the windows). This number represented the
percentage of laboratory measurements missing on average for a patient over a 24 hour
window. The patients were then split into 3 different groups based on the percentiles of
their missingness. Group 1 consisted of patients whose percentage of missingness fell be-
low 33 percentile of the overall cohort. Group 2 consisted of patients whose percentage of
missingness was above 33 percentile and below 66 percentile of the overall cohort. Group
3 consisted of patients whose percentage of missingness was above 66 percentile and below
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(a) (b)
* LR = Logistic Regression layer, FFNN = Feedforward Neural Network, WCPH = Weibull Cox Proportional
Hazard layer, FC = Fully Connected layer, AISE = Artificial Intelligence Sepsis Expert
Figure 3.5: Comparison of performance of baseline models and DeepAISE on the
MIMIC-III cohort to predict tsepsis−3 for prediction horizons of 2, 4, 6, 8, 10, and 12
hours. a) The Area Under the Curve (AUC) is shown in the left panel. b) The Specificity
(SPC) is shown in the right panel.
100 percentile of the overall cohort. The performance of DeepAISE (on the entire UCSD
cohort) for each of the above groups has been tabulated in Table 3.3. The Area under the
Receiver operating characteristic curves and Area under precision recall curves for Groups
1, 2 and 3 are shown in Figure 3.7 and Figure 3.8.
Table 3.3: Performance of DeepAISE on the entire UCSD cohort for differing levels of
missingness of input features. For reference, the percentage of missingness in Group 1 <
Group 2 < Group3. (AUC: Area under the receiver operating characteristic curve. AUCpr:
Area under the precision recall curve)
Total patients Septic patients AUC AUCpr
Group 1 6188 672 (10.85%) 0.871 0.278
Group 2 6188 561 (9.06%) 0.906 0.242
Group 3 6376 140 (2.19%) 0.916 0.179
Note: The Positive Predictive Value (or Precision) is defined as the ratio of number of
true positives to the sum of the true positives and false positives. In the scenario where
the class labels are highly imbalanced (in our case very low prevalence of positive labels
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Figure 3.6: The DeepAISE risk score crosses the decision threshold about 12 hours
prior to tsepsis−3. In this case, according to the definition of positive predictive value
all the positive predictions up until 4 hours prior to tsepsis−3 would be counted as false
positives. This is not clinically optimal, as earlier warnings are still relevant. In order
to not penalize the algorithm for making positive predictions before the expected 4 hours
prediction horizon, during the computation of PPV we considered any positive predictions
that occurred upto 24 hours prior to tsepsis−3 as true positives (the blue shaded region)
compared to negative labels), the positive predictive value (PPV) can get penalized by the
false positives to a very large extent. It is also often the case that the predicted risk scores
from a sequential prediction algorithm like DeepAISE can cross the decision threshold
earlier than the 4-hours prediction horizon. For example, the DeepAISE risk score crossed
the decision threshold about 12 hours prior to tsepsis−3 for the patient shown in Figure
3.6. In this case, according to the definition of positive predictive value all the positive
predictions up until 4 hours prior to tsepsis−3 would be counted as false positives. This is
not clinically optimal, as earlier warnings are still relevant. In order to not penalize the
algorithm for making positive predictions before the expected 4 hours prediction horizon,
during the computation of PPV we considered any positive predictions that occurred upto
24 hours prior to tsepsis−3 as true positives (the blue shaded region in Figure 3.6). The
AUCpr tabulated in Table 3.3 consists of PPV computed as described above.
43
Figure 3.7: Area under the receiver operating characteristic curves for Groups 1, 2
and 3.
Figure 3.8: Area under the precision recall curves for Groups 1, 2 and 3.
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3.2 PART II: Clinical interpretation of DeepAISE predictions and tele-ICU work-
flow integration
While performance characteristics of machine learning algorithms are important, providing
interpretable data to the bedside clinicians that can guide diagnosis and therapeutic inter-
ventions is a critical requirement of CDS systems. To date many sepsis models have failed
to demonstrate which physiologic aberrations contributed to the model’s prediction, com-
pelling many to refer to them as “black boxes”. In this section, we focus on the clinical
utility of DeepAISE by studying in detail the interpretability of its predictions. The goal of
any CDS system is to improve patient outcomes and reduce hospitalization costs; however,
actualization of these goals is incumbent upon clinical teams embracing and actually em-
ploying the technology. In this section, we also discuss the integration of DeepAISE into
a clinical workflow system and the stakeholders involved in developing the DeepAISE UI
(User Interface).
3.2.1 Testing the validity of the relevance scores and model interpretability
Unlike many other sepsis prediction algorithms, DeepAISE is uniquely interpretable wherein
apart from computing the sepsis risk score, the model identifies the most relevant features
contributing to the sepsis risk score as well. For a given risk score calculation the contribu-
tion of the individual input features was calculated using the associated relevance scores,
by calculating the gradient of the sepsis risk score with respect to all input features and
element-wise multiplication by the corresponding input features. The resultant scores, also
known as the relevance scores were then z-scored and the top 10 features (i.e., most fre-
quently observed features across patients and across time) with a z-score of larger than
1.96 (corresponding to a 95% confidence interval) were reported for analysis of the overall
importance of input risk factors (or global interpretability). To test the hypothesis that the
individual relevance scores capture meaningful information about the contribution of each
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input feature to the risk scores, we performed a series of studies in which we systemati-
cally masked (or treated as missing data): 1) the top 10 features with the largest positive
and negative relevance scores in a global sense (global feature replacement analysis), 2) the
top 10 locally important features for each individual risk scores (local feature replacement
analysis), and 3) a random set of 10 features at each point in time (repeated 100 times), and
calculated the resulting risk scores produced by DeepAISE and the corresponding AUCs.
More specifically, for the global feature replacement analysis, we identified 10 features that
appeared the most common as a top 10 relevant feature starting 10 hours prior to and until
tsepsis−3 (two separate analysis were run for the positive relevance scores and the negative
relevance scores). We then replaced these 10 global relevant features with the population
mean, for the entire cohort. For the local feature replacement analysis, for each hour that
a patient was in the ICU we computed the relevance score of all the input features, and re-
placed 10 of them with the highest positive (or negative) relevance score by their population
mean. This analysis allowed us to systematically compare the contribution of the locally
important features against the globally important predictors and against the 95-percentile
of a randomly selected set of features.
3.2.2 Understanding the effect of masking important features
In a nonlinear sequential model such as DeepAISE the relationship between the input fea-
tures and the model output is by no means obvious. As such, untangling this relationship
requires careful analysis.
In our analysis, we were interested in understanding the importance of features that
were positively and negatively contributing to the sepsis risk score. Features with posi-
tive relevance score: These were the features for which: 1) dY
dX
was positive and X was
positive (first quadrant in Figure 3.9a ) or 2) dY
dX
was negative and X was negative (second
quadrant in Figure 3.9b ). In both the above cases, when X is replaced with 0 (Note: All
the features are normalized to a standard normal distribution, hence population mean is 0),
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(a) (b)
Figure 3.9: Relationship between the output sepsis risk score and input. a) Plot of
sepsis risk score (Y) against a single variable X, when the slope is positive i.e. dY
dX
= +,
and b) Plot of Y against a single variable X, when the slope is negative i.e. dY
dX
= −
the sepsis risk score Y decreases. Thus, when features that have a positive relevance score
are replaced with the population mean, we would expect the sepsis risk score Y to drop.
This should result in decreased sensitivity (reduction in true positive rate) and increased
specificity (reduction in false alarm rate). Features with negative relevance score: These
were the features for which: 1) dY
dX
was positive and X was negative (second quadrant in
Figure 3.9a ) or 2) dY
dX
was negative and X was positive (first quadrant in Figure 3.9b ).
In both the above cases, when X is replaced with 0 (Note: All the features are normal-
ized to a standard normal distribution, hence population mean is 0), the sepsis risk score Y
increases. Thus, when features that have a negative relevance score are replaced with the
population mean, we would expect the sepsis risk score Y to increase. This should result
in increased sensitivity (increase in true positive rate) and decreased specificity (increase in
false alarm rate).
3.2.3 A case study of DeepAISE predictions
Note that the DeepAISE model used in the analysis henceforth was the model trained on
Emory cohort. All the results shown are for the Emory testing set.
Unlike many other algorithms, DeepAISE is uniquely interpretable as evidenced in
Figure 3.10 in which the trajectory of a septic patient who developed ventilator associated
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pneumonia in the ICU is displayed. In this visualization, the sepsis risk score predicted
by the model is shown along with vital sign trends, and most notably, the most relevant
features contributing to the risk score. In this example, early deterioration of the patient’s
respiratory status was detected by the model. The model identified aberrations in PaO2,
PaCO2, bloodpH and Glasgow coma score (GCS) as some of the top features relevant to
its prediction. The importance of each feature was calculated using the magnitude and sign
of the associated relevance scores, in a fashion similar to saliency maps for convolutional
neural networks [95].
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Figure 3.10: A clinically interpretable example of DeepAISE. The DeepAISE score is
shown for a septic patient according to the Sepsis-3 guidelines. The horizontal dashed
line indicates the prediction threshold corresponding to a sensitivity of 0.85. Commonly
recorded hourly vital signs of the patient, including heart rate (HR), mean arterial blood
pressure (MAP ), respiratory rate (RESP ), temperature (TEMP ), oxygen saturation
(O2Sat) are shown. The most significant features contributing to the DeepAISE score are
listed immediately below the DeepAISE Scores (for clarity of presentation, only selected
time points are shown). The horizontal dashed line indicates the prediction threshold cor-
responding to a sensitivity of 0.85. Refer to Section 3.4 for more details on the abbreviated
features
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3.2.4 Visualizing the most relevant features for sepsis prediction
Figure 3.11: Every hour DeepAISE identifies the top features contributing to an indi-
vidual septic patient’s risk score. The left subfigure demonstrates the frequency of the top
ten dynamic features (ordered according to the magnitude of the relevance score) across the
septic patient population (in the Emory cohort) preceding tsepsis−3 and the right subfigure
demonstrates the frequency of the top five static features that are seen preceding tsepsis−3.
Features with positive gradient with respect to the sepsis risk score are identified by ’(+)’.
Features with negative gradient with respect to the sepsis risk score are identified by ’(-)’.
To validate the clinical interpretability of the DeepAISE model, analysis of the most rel-
evant features starting 10 hours prior to and ending at tsepsis−3 was conducted (see Figure
3.11). This investigation revealed that DeepAISE ascribed importance to several features
that have already been identified as risk factors for sepsis such as recent surgery, length of
ICU stay, heart rate, GCS, white blood cell count, and temperature, and some less appre-
ciated but known factors such as Phosphorus (or hypophosphatemia) [96]. This analysis
provides a global view of model interpretability, whereas the individual relevance scores
provide a local view of interpretability by listing the top features contributing to the risk
scores for each hourly prediction window. Perturbation analysis revealed that the globally
important features may not provide an accurate view of the top contributing factors to the
individual risk scores. We observed that treating the top locally important features as miss-
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ing values yielded a significantly lower AUC compared with a similar analysis replacing
the globally most important features (See Figure 3.12).
Figure 3.12: Summary of performance of DeepAISE (on the Emory testing set) when
global feature replacement analysis and local feature replacement analysis were per-
formed for features with positive relevance score (left subfigure) and negative rela-
vance score (right subfigure). Note that the performance (AUC) of DeepAISE when a
random set of 10 features at each point in time were masked (repeated 100 times) was
0.899 [0.886, 0.901]. The sensitivity and specificity values reported for global feature
replacement analysis and local feature replacement analysis were measured at threshold
corresponding to 0.85 sensitivity for the original model.
3.2.5 Inferring significance of individual patient trajectories
Clinicians have long appreciated that trends in patient metrics are often more telling than
discrete point values. The high dimensional nature of the data used to represent a patient is
challenging to represent. Display of patient trajectories as they pass from states of sickness
to health provides yet another opportunity to inform the clinician about a patient’s expected
clinical course.
Each point on the manifold shown in Figure 3.13 is a 3D representation (projection)
of the patient’s 65 features, constructed via first learning a 100-dimensional representation
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Figure 3.13: Visualization of DeepAISE time series covariates performed by spectral
clustering, with septic patients represented by asterisk. The colors for the patients in
the plots were chosen based on the predicted sepsis risk score (green represents the lowest
predicted sepsis risk score, and red represents the highest predicted sepsis risk score).
(last layer of the DeepAISE model) followed by dimensionality reduction via Spectral clus-
tering [97]. The individual axes in Figure 3.13 denote a unique weighted combination of the
learned 100-dimensional representations, designed to construct a 3D space that preserves
the distance among the original data points as much as possible. Two exemplar 3D patient
trajectories are presented in Figure 3.14. Patient 2 was in a state of good health (specifically
no suspicion for infection) prior to developing a subdural hemorrhage which prompted ad-
mission. This patient went on to be diagnosed with a ventilator associated pneumonia two
days after an emergent craniectomy. In contrast Patient 1, who was several weeks status
post craniectomy for stroke, was readmitted with a culture positive pneumonia present on
admission. The manifold in Figure 3.14 shows that trajectories for patient 1 and 2 follow
similar terminal patterns; however, correctly assigns them different starting positions with
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patient 2 starting from a comparatively higher risk cluster. The specific trajectory of an
ICU patient may be useful in categorizing infectious phenotypes and detecting anomalous
physiological dynamics.
(a) (b)
Figure 3.14: Visualization of DeepAISE time series covariates performed by spectral
clustering. The trajectory of the DeepAISE score for 2 septic patients from ICU admission
until sepsis diagnosis is displayed below a larger manifold that makes use of spectral clus-
tering to visually display a patient’s physiologic journey through their illness (each point
on the graph represents one hour of data from one patient). The colors for both patients in
the plots are chosen based on the predicted sepsis risk score (green represents the lowest
predicted sepsis risk score, and red represents the highest predicted sepsis risk score). (A)
Patient #1 (P1) was a 63-year-old female admitted for a left sided subdural hemorrhage
who underwent a craniectomy on hospital day zero. This patient remained intubated after
surgery and began receiving treatment for a culture proven ventilator associated pneumonia
the afternoon of hospital day number three. DeepAISE identified this patient as being septic
nearly 24hrs before clinical treatment was implemented (See Figure 3.17). (B) Patient #2
(P2) was a 70 year old male who was admitted for altered mental status and seizures after
vascular coiling of a middle cerebral artery (MCA) aneurysm. P2 was intubated on admis-
sion and began treatment for a culture proven ventilator associated pneumonia on hospital
day five however DeepAISE made its sepsis prediction nearly 36 hours prior to this time,
after demonstrating a steadily worsening score since admission (See Figure 3.18).
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3.2.6 DeepAISE user interface and tele-ICU workflow integration
The goal of any CDS system is to improve patient outcomes and reduce hospitalization
costs; however, actualization of these goals is incumbent upon clinical teams embracing
and actually employing the technology. The integration of a CDS system into clinical
workflows depends on many factors, and therefore the development of the DeepAISE UI
(User Interface) involved nursing stakeholders in our tele-ICU center. Appreciating the
workflow of the tele-ICU staff was a critical component of ensuring that the developed UI
was both useable and interpretable. Nursing stakeholders identified the key tasks in the
tele-ICU as consisting of the following: routine patient assessment, sepsis risk assessment,
communication with the bedside clinical team, and physician initiation of therapeutic in-
terventions. A minimal user interface (UI) that enhanced workflow awareness, provided
easy actionability, and ensured data integrity was built after soliciting requirements from
the aforementioned stakeholders in early 2017. The resultant UI shown in Figure 3.15 was
designed to present a list of patients sorted by DeepAISE risk score for predicting tsepsis−3
four hours in advance. Square cards that include the sepsis risk score as well as the change
in score over the past hour are used to represent a single patient. Individual cards can
be flipped via a single mouse-click to reveal the top factors contributing to the presented
score. To improve individual and unit situational awareness regarding patient interventions
and assessments, users can drag-and-drop patient cards into columns representing different
treatment categories.
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Figure 3.15: Screenshot of the clinician facing DeepAISE UI. In the left column, patients
are ranked in decreasing severity of illness. An individual patient card shows DeepAISE
score on the front, and upon a single mouse click the card is turned displaying the top
causes contributing to the risk score (e.g. Temperature, Heart Rate, Platelets). The middle
column displays patients that have undergone review by a clinician. The right most column
displays patients for whom treatment has been initiated.
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3.3 Discussion
In this work, a deep learning model was used to automatically learn complex features, in-
cluding temporal trends and higher-order interactions among the risk factors, to accurately
predict the likelihood of sepsis in patients admitted to the ICU up to 12 hours in advance.
Additionally, satisfaction amongst users of our CDS system was most greatly impacted by
the enhancement of clinical interpretability of the findings through a workflow-aware UI
that incorporated a patient’s trajectory and the key factors contributing to their risk score.
DeepAISE was developed to predict tsepsis−3 (Sepsis-3 criterion) in this study. We ob-
served that the four hours ahead prediction AUC of DeepAISE (on Emory testing set) was
0.90 for tsepsis−3. Additionally, the performance of DeepAISE expectedly dropped as the
prediction window increased from 2 to 12 hours. All these findings were externally repro-
duced with the UCSD and MIMIC-III patient cohorts, providing supporting evidence that
the DeepAISE algorithm can be tailored and applied to a geographically diverse patient
population.
Another advantage of the proposed deep learning approach is in its ability to provide the
top factors contributing to the risk score for every point in time for each patient (i.e., local
interpretability). The distinction between the global and local notions of interpretability
(i.e., what features are contributing to the sepsis risk score for the cohort at large versus an
individual patient’s hourly prediction window) is most notable when dealing with models
capable of capturing higher order interactions and temporal trends in the data. As a result,
the degree of risk associated with a factor (e.g., temperature) is a function of other factors in
a multiplicative sense (e.g., hypothermia and old age are together a greater risk factor than
either by itself). Similarly, the temporal context of a risk factor can alter its contribution
to a given risk score calculation (e.g., leukocytosis immediately after surgery may not be
unexpected and may contribute differently to the risk for sepsis). These multiplicative and
temporal factors (which are captured by the DeepAISE model) result in variations in the
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importance of risk factors when viewed from a local, hourly prediction perspective for each
patient. Note that traditional logistic regression models and decision trees are not capable
of making such inferences unless the relevant features are hand-crafted by the experts and
included in the model.
The DeepAISE algorithm was implemented in a real-time setting and a decision sup-
port user interface (UI) was designed to communicate the risk scores to the clinical team.
A major barrier to wide adoption of modern machine learning based CDS tools in clini-
cal practice has been their “black box” nature [41]. While it is important to design deep
learning models with high performance, it is imperative to build models that provide inter-
pretable data to bedside clinicians that can augment their understanding of the disease pro-
cess and can contribute to the selection and initiation of appropriate treatments. DeepAISE
was designed to be transparent by: 1) continually revealing the top causes contributing to
the sepsis risk score (see Figure 3.10), 2) providing a lower dimensional view of the pa-
tients’ trajectory (see Figure 3.11), and 3) providing a prioritized list of patients at risk for
sepsis (see Figure 3.15). These three attributes allow the bedside clinician to identify patho-
logic deviations from expected physiology early and in real-time throughout the duration
of patients’ hospital admission. Incorporation of these top causes in the DeepAISE UI con-
tributed to user satisfaction in our preliminary study. Further longitudinal usability studies
are required to validate the utility of this feature to improve situational awareness and as-
sist clinicians with independent evaluation of patient’s risk for sepsis prior to initiation of
interventions.
We have shown that the top causes can be broken down into two categories of positively
and negatively contributing factors to the risk score. Notably, this analysis shed insight on
the input features contributing significantly to the sensitivity (positive contributors) and
specificity (negative contributors) of DeepAISE (see Figure 3.12). Since one of the key
limitations of using EHR data is the intermittent nature of laboratory measurements, we
hypothesize that one may use the knowledge of the top contributing factors to protocolize
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the ordering of laboratory tests, to ensure specific updated measurements of these factors
are available to the algorithm, thus improving model sensitivity and specificity. Our results
indicate that the degree of data missingness was inversely correlated with the prevalence
of sepsis within a given subgroup of patients (see Table 3.3). DeepAISE had the highest
AUC on the sub-group with the highest level of missingness and the lowest prevalence of
sepsis; since data missingness pushes the risk score to lower values which translates to
more specific predictions at the cost of reduced sensitivity and positive predictive value.
The net effect was a higher AUC due to the higher prevalence of negative labels within
this subgroup. Further work is required to assess the performance of DeepAISE under
varying degrees of missingness of the top contributing factors to the risk score. This is
particularly important as one extends such algorithms to non-ICU units where patients are
not as frequently monitored.
In recent years, several machine learning-based models for early prediction of sepsis
and septic shock have been proposed; although variations in experimental design and def-
initions of sepsis make a direct comparison of these methods impractical. Desautels et al.
[23] proposed a proprietary machine learning model called InSight to predict sepsis in ICU
patients. Their model used a combination of vital signs, pulse oximetry, GCS, and age as
input features. An earlier version of this algorithm relied on the Sepsis-3 definition (specif-
ically tSOFA) to train its model and was able to reliably identify (detect) patients at the time
they had met the Sepsis-3 criteria, with a 4-hours ahead prediction AUC of 0.74, which is
comparable to performance reported by Amland et al. [98]. Following the Sepsis-3 defini-
tion, Nemati et al. [25] achieved an AUC of 0.85 for 4 hours ahead prediction of sepsis, by
combining 65 data points including low-resolution data from the EHR and high-resolution
vital sign time series features from the bedside monitors. The superior performance of
DeepAISE in comparison to the abovementioned models can be attributed to employment
of an RNN-based model that captures patients’ clinical trajectory.
Experimental design can have a pronounced effect on the reported AUC of machine
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learning algorithms. A commonly utilized method known as the ‘case-control’ design
(which includes the majority of studies involving biomarkers) significantly overestimates
the true prevalence of positive labels and can result in highly optimistic reported perfor-
mances in the literature when compared to a ‘sequential prediction’ design [25]. Assuming
a sepsis prevalence of 8% in the ICU population (after excluding all cases of sepsis de-
veloped before ICU admission), a median time-to-sepsis of 23 hours, and a 4-hours ahead
prediction window, typically only 1-2% of the observed windows include a positive label
for sepsis. The case-control study design assumes the timing of sepsis is known a priori
and seeks to show that certain physiological or biomarker signatures preceding this time are
significantly different than that of the non-septic control patients. The resulting algorithms,
which are tuned to a 50% prevalence of positive labels, tend to produce high rates of false
alarms when deployed prospectively.
In general, statistical evaluation methods (such as the AUC) have a limited applicability
when evaluating the clinical utility of such algorithms, although they can provide quanti-
tative metrics for the comparison of various algorithms. In practice, performance metrics
are only meaningful when coupled with appropriate clinical protocols that describe the
course of action in response to the associated risk alerts. Simple clinical actions (such as
‘snoozing’ the alarm for X hours if the patient did not meet the clinical threshold to ini-
tiate therapy) can significantly alter the false-alarm rate (defined as 1-Specificity) and the
associated AUC of an algorithm in practice.
While we have strictly adhered to the Sepsis-3 criteria for defining septic labels in our
study, it has been noted that this criterion is too stringent and the sensitivity of early detec-
tion is lost to an increased specificity [99, 100]. The Sepsis-3 criterion utilized in this study
is an acausal clinical construct for demarcating the onset time of sepsis, and as such cannot
be used in a clinical setting for early detection of sepsis; however, a predictive analytic risk
score when trained to predict the associated onset-time can combine the specificity advan-
tages of Sepsis-3 with the benefits of early recognition. Moreover, it is critical to appreciate
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that making a clinical diagnosis of sepsis carries much greater value than simply identifying
‘poor health’ or general decompensation. True cases of sepsis can be positively impacted
by the rapid administration of broad-spectrum antibiotics, IV fluids, and vasopressors if
indicated [10, 13] where as “decompensated” patients still need further assessment to as-
certain the etiology of the deterioration and to determine appropriate intervention.
A potential use case of DeepAISE is to facilitate compliance with standardized care
bundles such as SEP-1 [19], which advocates for obtaining blood cultures, administering
broad spectrum antibiotics, measuring lactate, and starting appropriate fluid resuscitation
if clinically indicated, all within 3 hours of clinical recognition of sepsis. We anticipate
that a likely clinical workflow may include: 1) flagging of a patient by the DeepAISE risk
score with a prediction horizon of 4 hours, 2) independent evaluation of the patient by a
bedside caregiver (this may include ordering of additional labs such as lactate), 3) followed
by ordering of cultures prior to ordering of antibiotics, and 4) completion of the SEP-1
bundle components. The predictive ability of DeepAISE and enumeration of top causes
contributing to the risk score is remarkable because clinicians will be able to independently
evaluate the algorithm’s rationale for flagging a patient, and when clinically appropriate
begin implementing components of the sepsis bundle much earlier. In fact, a recent study
provided critical evidence [101] that longer intervals from antibiotic order to infusion are
associated with higher mortality rates in septic and septic shock patients, thus emphasizing
the importance of improving workflow related factors to the care of this patient population.
Sepsis survivors often suffer from high rates of readmission [102] and many survivors
of sepsis face life-long, debilitating sequelae as a result of the disease [103]. Future exten-
sions of this work will involve performing prospective clinical trials to validate DeepAISE’s
real-time predictions in a clinical setting; however, our findings provide significant clinical
evidence for a radical change to the sepsis treatment paradigm that has real-time high-




The complete list of the input features to the model is as follows -
1. High-resolution dynamical features (calculated using 6 hours sliding windows, with
5 hours overlap; 6 features)
• standard deviation of RR intervals and Mean Arterial Blood Pressure (RRSTD
andMAPSTD), average multiscale entropy of RR and MAP (HRV1 andBPV1)
and average multiscale conditional entropy of RR and MAP (HRV2 andBPV2).
2. Clinical features (10 features)
• Mean Arterial Blood Pressure (MAP ), Heart Rate (HR), Oxygen Saturation
(O2Sat), Systolic Blood Pressure (SBP ), Diastolic Blood Pressure (DBP ),
Respiratory Rate (RESP ), Temperature (Temp), Glasgow Coma Scale (GCS),
Partial Pressure of Arterial Oxygen (PaO2), Fraction of Inspired O2 (FiO2).
3. Laboratory (General; 25 features)
• White Blood Count (WBC), Hemoglobin, Hematocrit, Creatinine, Bilirubin
and Bilirubin Direct, Platelets, International Normalized Ratio (INR), Partial
Prothrombin Time (PTT ), Aspartate Aminotransferase (AST ), Alkaline Phos-
phatase, Lactate, Glucose, Potassium, Calcium, Blood rea nitrogen (BUN ),
Phosphorus, Magnesium, Chloride, B-type Natriuretic Peptide (BNP ), Tro-
ponin, Fibrinogen, CRP, Sedimentation Rate, Ammonia.
4. Laboratory (Arterial Blood Gas or ABG; 5 features):
• pH , pCO2, HCO3, Base Excess, SaO2.
5. Demographics/History/Context (19 features)
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• Care Unit (Surgical, Cardiac Care, or Neurointensive care), Surgery in the past
12 hours, Wound Class (clean, contaminated, dirty, or infected), Surgical Spe-
cialty (Cardiovascular, Neuro, Ortho-Spine, Oncology, Urology, etc.), Number
of antibiotics in the past 12, 24, and 48 hours, Age, Charleston Comorbidity
Index (CCI), Mechanical Ventilation, maximum change in SOFA score over
the past 6 hours
Table 3.4: Summary of Emory testing set prediction performance of DeepAISE
model in predicting tsepsis−3 four hours in advance. The DeepAISE model con-
sists of a 2 layer GRU, a fully connected layer and WCPH model. The Area
Under the Curve (AUC), Specificity (SPC) and Accuracy (ACC) are reported
for both training set and testing set
Testing set (Training Set)
Model AUC SPC ACC
LR 0.87 (0.89) 0.76 (0.79) 0.76 (0.79)
FFNN (1 hidden layer) + LR 0.88 (0.92) 0.76 (0.85) 0.77 (0.85)
FFNN (2 hidden layers) + LR 0.87 (0.92) 0.76 (0.85) 0.78 (0.85)
WCPH 0.84 (0.86) 0.64 (0.71) 0.64 (0.71)
FFNN (1 hidden layer) + WCPH 0.88 (0.92) 0.77 (0.85) 0.77 (0.85)
FFNN (2 hidden layers) + WCPH 0.87 (0.93) 0.75 (0.88) 0.75 (0.88)
2 layer GRU + FC + LR 0.88 (0.90) 0.78 (0.88) 0.78 (0.88)
DeepAISE 0.90 (0.94) 0.80 (0.89) 0.78 (0.82)
* LR = Logistic Regression layer, FFNN = Feedforward Neural Network, WCPH
= Weibull Cox Proportional Hazard layer, FC = Fully Connected layer, AISE =




* LR = Logistic Regression layer, FFNN = Feedforward Neural Network, WCPH = Weibull Cox Proportional
Hazard layer, FC = Fully Connected layer, AISE = Artificial Intelligence Sepsis Expert
Figure 3.16: Comparison of Emory testing set performance of all baseline models and
DeepAISE to predict tsepsis−3 for prediction horizons of 2, 4, 6, 8, 10, and 12 hours.
The Area Under the Curve (AUC) is shown in the left panel. The Specificity (SPC) is
shown in the right panel.
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Table 3.5: Summary of patient characteristics of Emory ICU cohort
Model All Patients Non-Septic Septic
Patients, (#) 25820 24375 1445
6%
Male, no. (%) 53.3 53.2 55.2
Age, median (IQR) y 61 61 61.5
[49 - 71] [49 - 71] [50.5 - 72]
Race, no. (%)
Caucasian 48.6 48.9 45.0
Black 43.3 43.1 45.4
Asian 1.3 1.3 1.3
Hispanic 0.024 0.02 0.08
Surgery (%)
Cardiovascular 13.1 - -
Neuro 6.1 - -
Ortho-spine 1.8 - -
Oncology/General Surgery 3.6 - -
Urology 0.4 - -
ICU LOS, median (IQR) h 48 46 141
[28 - 90] [27 - 77] [77 - 258]
Inpatient Mortality, % 4.1 3.5 15.2
Inpatient Hospice, % 3.8 3.3 12.5
SOFA, median (IQR) 1.9 1.7 5.0
[0.6 - 4.0] [0.5 - 3.6] [3.1 - 7.4]
CCI, median (IQR) 2 2 3
[1 - 4] [1 - 4] [2 - 5]
ICU Admission to tsepsis−3, - - 24
median (IQR) h [9 - 63]
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Table 3.6: Summary of patient characteristics of UCSD ICU cohort
Model All Patients Non-Septic Septic
Patients, no. 18752 17679 1073
5.7%
Male, no. (%) 61.1 60.8 66.5
Age, median (IQR) y 59.8 59.7 60.8
[46.4 - 70.8] [46.3 - 70.8] [46.9 - 70.3]
Race, no. (%)
Caucasian 52.2 52.5 47.4
Black 7.9 7.9 6.2
Asian 5.4 5.4 6.4
ICU LOS, median (IQR) h 44.8 43.3 143.8
[24.3 - 79.6] [23.8 - 72.9] [78.5 - 241.2]
Mortality, % 4.7 3.7 21.1
SOFA, median (IQR) 2 1 4
[0 - 4] [0 - 3] [2 - 6]
CCI, median (IQR) 3 2 3
[1 - 6] [1 - 3] [2 - 6]
ICU Admission to tsepsis−3, - - 38
median (IQR) h [16 - 74]
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Table 3.7: Summary of patient characteristics of MIMIC-III ICU cohort
Model All Patients Non-Septic Septic
Patients, no. 40474 38198 2276
5.6%
Male, no. (%) 56.5 56.3 58.8
Age, median (IQR) y 66 65 66
[52 - 77] [52 - 77] [50 - 71]
Race, no. (%)
Caucasian 71.6 71.5 72.4
Black 9.2 9.2 8.6
Asian 2.2 2.2 2.4
Hispanic 3.4 3.4 3.4
ICU LOS, median (IQR) h 47 45 158
[27 - 88] [26 - 74] [83 - 266]
Mortality, % 8.9 8.1 22.0
SOFA, median (IQR) 1.6 1.5 3.3
[0.65 - 3.1] [0.6 - 2.9] [2.0 - 5.1]
CCI, median (IQR) 2 2 3
[1 - 3] [1 - 3] [1 - 4]
ICU Admission to tsepsis−3, - - 31.2
median (IQR) h [13.3 - 70.2]
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Figure 3.17: DeepAISE score shown for Patient #1 (P1). Commonly recorded hourly
vital signs of the patient, including heart rate (HR), mean arterial blood pressure (MAP ),
respiratory rate (RESP ), temperature (TEMP ), oxygen saturation (O2Sat) are shown.
The most significant features contributing to the DeepAISE score are listed immediately
below the DeepAISE Scores (for clarity of presentation, only selected time points are
shown). The horizontal dashed line indicates the prediction threshold corresponding to
a sensitivity of 0.85. Refer to Appendix C of Supplementary Material for more details on
the abbreviated features.
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Figure 3.18: DeepAISE score shown for Patient #2 (P2). Commonly recorded hourly
vital signs of the patient, including heart rate (HR), mean arterial blood pressure (MAP ),
respiratory rate (RESP ), temperature (TEMP ), oxygen saturation (O2Sat) are shown.
The most significant features contributing to the DeepAISE score are listed immediately
below the DeepAISE Scores (for clarity of presentation, only selected time points are
shown). The horizontal dashed line indicates the prediction threshold corresponding to




COMPOSER - DEVELOPMENT AND VALIDATION OF A GENERALIZABLE
MODEL FOR EARLY PREDICTION OF SEPSIS USING CONFORMAL
METHODS AND DOMAIN ADAPTATION
4.1 Introduction
Acute care facilities and in particular intensive care units (ICUs) provide an environment
where an immense amount of data is acquired, and it is expected that with the advent of
wearables and biometric patches even more continuously recorded data will be available
in such settings [104, 105]. But at present, very little of these data are used in a real-time
setting to prognosticate effectively, and the existing machine learning (ML) and predictive
analytics risk scores (many of them only tested retrospectively) suffer from lack of general-
izability across institutions and performance degradation within the same institution across
time [48]. This limited generalizability is due to number factors including differences in
local populations, EHR systems, coding definitions, laboratory equipment and assays, as
well as variations in clinical and administrative practices. For instance, in a recent study
aimed at detecting abnormal chest radiographs, the specificity of an ML model at a fixed
operating point varied widely, from 0.566 to 1.000, across five independent datasets [106,
107]. Similarly, most existing published clinical ML and predictive analytic models are
either based on data from a single hospital [26, 31] or multiple hospitals from the same
healthcare system [49] where the processes of care are mostly standardized. Although less
common, clinical ML models that have been validated across different healthcare systems
are either re-trained from scratch or are fine-tuned (via transfer learning) on every new pa-
tient cohort [25, 50], or when applied out-of-the-box often exhibit significant degradation
in performance [51].
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Finally, as the processes of care are often variable across different levels-of-care (Emer-
gency Departments, ICUs, and step-down units/general wards) and the degree of data miss-
ingness is commonly a function of illness severity [52], ML algorithms typically have to
be optimized for different levels-of-care and patient type. This observation has prompted
some researchers to suggest that exploiting the patterns of data missingness (e.g., presence
or absence of laboratory tests) might be useful for assessment of risk, with one single-center
study suggesting 4-5 point improvement in AUC when including missing data indicators
as features into a 30-day mortality prediction model [108]. In our experience, such models
often perform extremely poorly when applied to data from other healthcare systems, where
the frequency of measurement of labs is also tied to other workflow-related factors. More-
over, the re-training of models is typically expensive and impractical (namely due to the
difficulty of obtaining gold-standard labels). Finally, regulatory guidelines surrounding the
re-training of ML algorithms, categorized under Software as a Medical Device (SaMD),
remain unclear [109]. In spite of tremendous interests and hypes around the application of
ML algorithms, the above-mentioned factors have impeded the process of evidence gener-
ation, commercialization, and wide-adoption of these tools.
As noted by Agniel et al.[52], while without careful considerations of context, EHR
data may be unsuitable for answering many research questions. However, when healthcare
processes are adequately addressed and incorporated into ML models through introduction
of inductive biases (i.e., necessary and appropriate assumptions built into model archi-
tecture, learning process, and application/deployment) such data can be leveraged to gain
insight into patients’ state of health. The work proposed in this chapter addresses these
key gaps in generalizability, including 1) modeling of variations in frequency of labora-
tory measurements across levels-of-care and different healthcare systems (also related to
data missingness), 2) handling of data/population drifts (aka, data distribution shifts), and
3) explicitly quantifying the conditions for use of an algorithm via design of algorithmic
controls.
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The primary contributions of the work proposed in this chapter are as follows:
• We propose a weighted input layer that is designed to handle missing data and vari-
ations in data measurement frequency across various levels of care (Emergency De-
partment, ICU etc.) and different institutions.
• We utilize the technique of Adversarial Domain Adaptation (ADA) [110] to learn
representations that minimize healthcare system specific variations. A key impor-
tance of utilizing ADA training procedure is the design of a predictive model that
can adapt to new unlabeled target patient population; therefore, gold-standard labels
which are often expensive to obtain, are not required to deploy the model at a new
center.
• We also provide a framework that combines representation learning [111] and ideas
from conformal methods [112, 113, 114, 115] for establishing the ‘conditions for
use’ of a clinical model. This enables us to explicitly determine at what level of data
covariance shift one may still trust a clinical risk score [116].
The proposed framework utilizes all three of the above contributions to make a Conformal
Multidimensional Prediction of Sepsis Risk (COMPOSER) Score for the onset of sepsis
within a four hour prediction horizon. We show the generalizability of COMPOSER model
by utilizing data from over 480,000 patients collected between 2016-2019 from three dif-
ferent academic medical centers in the US, including data from Emergency Departments
(EDs), Intensive Care Units (ICUs), and general wards. The rest of the chapter discusses
in detail the datasets used in this study, the development of COMPOSER model and the
results obtained by applying COMPOSER model on these datasets.
4.2 A multicenter dataset of patients in Emergency Department and ICU
In this study, we collected data from three different academic medical centers in the US to
make up a total of five different patient cohorts (Refer to Table 4.17, Table 4.18 and Table
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4.19 for a summary of patient characteristics for each of the five cohorts used in this study).
This investigation was conducted according to UCSD IRB approved protocol #191098X.
The Hospital-A ICU cohort was drawn from the Electronic Health Record (EHR) data of
all patients admitted to the ICUs at two hospitals within the Hospital-A health system from
2016 to 2019. The Hospital-B ICU cohort was drawn from the EHR data of all patients
admitted to the ICUs at two hospitals within the Hospital-B health system from 2014 to
2018. The Hospital-C ICU cohort was drawn from EHR data of all patients admitted to the
ICUs at Hospital-C from 2016 to 2017. Patients 18 years or older were followed throughout
their ICU stay until discharge or development of sepsis according to Sepsis-3 guidelines
[1, 16]. For all the above ICU cohorts, we excluded patients if they developed sepsis
within or prior to the first four hours of ICU admission (by analyzing pre-ICU IV antibiotic
administration and culture acquisition) or if their length of ICU stay was less than 8 hours
or more than 20 days.
The fourth cohort was the Hospital-A ED cohort which consisted of all patients ad-
mitted to the Emergency Departments (EDs) at two hospitals within the Hospital-A health
system from 2016 to 2019. The fifth cohort was the Hospital-B ED cohort which consisted
of all patients admitted to the Emergency Departments (EDs) at two hospitals within the
Hospital-B health system from 2014 to 2018. For both the above ED cohorts, patients 18
years or older were followed throughout their ED stay until discharge or development of
sepsis according to Sepsis-3 guidelines [16, 1]. Additionally, we excluded patients if they
developed sepsis within or prior to the first 2 hours of ED admission or if their length of
ward stay was less than 3 hours or more than 20 days.
The Hospital-A ICU cohort contained a total of 18990 patients, 1236 (6.5%) of whom
met the Sepsis-3 criterion four hours or later after ICU admission. Out of the 18990 pa-
tients 70% of them were used for developing the COMPOSER model (training set), 10%
were used as validation set and the remaining 20% formed the testing set. Note that the
proportion of the splits were the same for both septic and non-septic patients. The Hospital-
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B ICU cohort contained a total of 45679 patients, 2563 (5.6%) of whom met the Sepsis-3
criterion four hours or later after ICU admission. The Hospital-C ICU cohort contained
a total of 7426 patients, 229 (3.1%) of whom met the Sepsis-3 criterion four hours or
later after ICU admission. The Hospital-A ED cohort contained a total of 86869 patients,
1308 (1.5%) of whom met the Sepsis-3 criterion 2 hours or later after ED admission. The
Hospital-B ED cohort contained a total of 325916 patients, 6236 (1.9%) of whom met the
Sepsis-3 criterion 2 hours or later after ED admission. For the Hospital-A ICU/Hospital-A
ED/Hospital-B ED cohorts, 80% of the patients were used for developing the COMPOSER
model and the remaining 20% formed the testing set. For the Hospital-C ICU cohort, 70%
of the patients were used for developing the COMPOSER model and the remaining 30%
formed the testing set. Please refer to Table 4.17 for more details and comparison amongst
all the five cohort used in this study.
Additionally, in terms of number of one-hour windows, the Hospital-A ICU dataset
consisted of a total of 725,886 windows out of which 717,468 (98.9%) windows were non-
septic and 8418 (1.1%) were septic. The Hospital-B ICU dataset consisted of a total of
1,747,139 windows out of which 1,729,275 (98.9%) windows were non-septic and 17,864
(1.1%) were septic. The Hospital-C ICU dataset consisted of a total of 284,570 windows
out of which 283,006 (99.4%) windows were non-septic and 1564 (0.6%) were septic.
The Hospital-A ED dataset consisted of a total of 762,103 windows out of which 755,432
(99.1%) windows were non-septic and 6671 (0.9%) were septic. The Hospital-B ED dataset
consisted of a total of 1,938,829 windows out of which 1,909,181 (98.4%) windows were
non-septic and 29,648 (1.6%) were septic.
4.3 Clinical variables for model development
A total of 40 clinical variables (34 dynamic and 6 demographic variables) were extracted
based on their association with onset of sepsis and their availability in EHR across the
different hospitals considered in our study [25, 117, 22]. These included vital signs mea-
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surements (heart rate, pulse oximetry, temperature, Systolic blood pressure, mean arterial
pressure, diastolic blood pressure, respiration rate and end tidal carbon dioxide), laboratory
measurements (bicarbonate, measure of excess bicarbonate, fraction of inspired oxygen,
pH, partial pressure of carbon dioxide from arterial blood, oxygen saturation from arterial
blood, asparate transaminase, blood urea nitrogen, alkaline phosphatase, calcium, chloride,
creatinine, bilirubin direct, serum glucose, lactic acid, magnesium, phosphate, potassium,
total bilirubin, troponin, hematocrit, hemoglobin, partial thromboplastin time, leukocyte
count, fibrinogen and platelets) and demographic variables (age, gender, identifier for med-
ical ICU unit, identifier for surgical ICU unit, length of hospital stay, length of ICU stay).
All vital signs and laboratory variables were organized into 1-hour non-overlapping time
series bins to accommodate for different sampling frequencies of available data. The 1-
hour time bin interval was selected as a balance between having short windows with too
many missing data points (low frequency clinical data) and having time windows too long
to make any meaningful prediction. All the variables with sampling frequencies higher
than once every hour were uniformly resampled into 1-hour time bins, by taking the me-
dian values if multiple measurements were available. Variables were updated hourly when
new data became available; otherwise, the old values were kept (sample-and-hold interpo-
lation). Mean imputation was used to replace all remaining missing values (mainly at the
start of each record). Additionally, for every vital signs and laboratory variable, the time
since the variable was last measured (TSLM) was recorded.
In the later part of this chapter, we will refer to the 34 dynamical variables byXdyamical,
the TSLM features by XTSLM and the 6 covariate features by Xcovar. All of the above
features together make up 74 features.
4.4 Development of the COMPOSER model
The COMPOSER model is designed to operate sequentially over the EHR data of a patient.
Starting from beginning of a patient record, the predictive model is fed with the input
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Figure 4.1: Schematic diagram of the COMPOSER model during testing phase. The
test data point is first passed through the weighted input layer along with the TSLMs for
each of the 34 dynamical variables. The output from the weighted input layer is then
fed into the encoder to obtain a lower dimensional feature vector of the input. This feature
vector is then fed into the conformal predictor, which compares the feature vector with other
representations present in the calibration set to determine if the test data point belongs to
the same probability distribution of the calibration or not. If yes (p ≥ ε), the feature vector
is passed onto the sepsis predictor to obtain the probability of onset of sepsis.
features (as described in Section 4.3) to obtain hourly predictions of the probability of
onset of sepsis (tsepsis−3) within the next four hours. Whenever the predicted probability
crosses a decision threshold, it is considered to be a positive prediction for onset of sepsis.
The main contributions of this work are in the design of a generalizable model using a
constrained deep learning architecture with domain adaptation, and the demonstration of
its generalizability – on five different patient cohorts and across different levels of hospital
care (ICU vs ED) – in making effective predictions for onset of sepsis.
Figure 4.1 provides the overall schematic diagram of the COMPOSER model during
testing/inference phase. In this phase, the dynamic variables are first fed into the weighted
input layer to obtain a scaled feature vector. A combination of the scaled feature vector
and demographic variables are then fed into the encoder module. The encoder module
transforms the high dimensional input feature vector into a lower dimensional represen-
tation that captures all information relevant to prediction of onset of sepsis. The lower
dimensional vector obtained from the encoder module is then passed through the confor-
mal predictor to detect any distributional shift. If no distribution shift is detected, it is then
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passed through the sepsis predictor to obtain a probability score for onset of sepsis within
the next four hours.
4.4.1 Weighted input layer
In this study, we make use of 34 laboratory and vital measurement data available in the
EHR for helping distinguish healthy from septic patients. There are two challenges that
exist when using dynamical variables and their contextual information for building predic-
tive models. First, while a laboratory test’s value can provide information about the state
of health of a patient, it has been shown that laboratory test measurement patterns provide
complementary information in addition to the values of the laboratory tests themselves
[118]. This should however be treated with caution when the aim is to develop a gener-
alizable predictive model since some of the tests (such as basic metabolic panel, calcium,
phosphorous, magnesium) are ordered based on guidelines set by a hospital protocol, and
these protocols can i) vary within a hospital across different levels of care (ICU vs Ward vs
ED) and ii) vary from one hospital to another for the same level of care (Hospital A ICU
vs Hospital B ICU). Due to the differing measurement patterns (and differing healthcare
processes), a predictive model trained on data from Hospital A ICU can perform poorly
on data from Hospital B ICU. Second, when a sample-and-hold approach is used for in-
terpolation, there is no sense of the extent to which an interpolated value can be trusted.
For example, heart rate is a highly variable feature and a measurement that was made more
than 6 hours ago often does not represent the current physiological status of a patient and in
such a scenario the interpolated value can misguide a predictive model. On the other hand,
there are variables (such as lactate measurement) whose values are valid for longer dura-
tions after they have been measured. In order to address the above problems, we propose
a weighted input layer that scales the latest measured value of a variable depending on the
duration since it was measured. The extent of scaling is controlled by a parameter that is
learned from the data. Let us considerXnt to be the 34 dimensional vector (consisting of all
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dynamical variables) at time t for patient n. Henceforth, with a slight abuse of notation we
will refer to Xnt by Xt, wherein Xt = [x1,t, ;x2,t; ...x34,t], xi,t ∈ R. Next δi,t corresponds
to the duration since variable i was last measured (in reference to the current time t). Each
of the variables xi,t is then non-linearly weighted based on the duration since it was last
measured, to obtain xwi,t = xi,t ∗ f(δi,t, αi).
The weighting function f(.) is defined as follows:
f(δi,t, αi) = 2 ∗
(
1− 1
(1 + exp(−α2i ∗ δi,t))
)
(4.1)
Where αi is a scaling factor for each of the dynamical variable and is learned during the
training of the model. Thus, the output of the weighted input layer is a 34 dimensional






34,t]. The scaling factors αi (for each dynamic vari-
able) obtained at the end of training the COMPOSER model should reflect the extent of
interpolation that is useful for predicting the onset of sepsis.
4.4.2 Adversarial domain adaptation
The arrival of Big Data in healthcare has provided an impetus to development of data-driven
machine learning models (deep learning models) that are aimed at improving healthcare
delivery to patients [119, 120, 121, 122, 123, 124]. A main concern with such data-driven
deep learning models are that they might not generalize to unseen datasets that might have
differing distributions of data, eg. A model trained using Hospital A ICU data (source
domain) deployed at Hospital B ICU (target domain). This distributional differences in
data (which in turn can lead to poor generalization in performance of such models) can
arise due to wide variety of factors – shifts in demographic characteristics, shifts in baseline
data measurements (due to change in measuring instruments), shifts in level of care, change
in healthcare delivery protocol etc.
Domain adaptation could be a natural solution to this issue, wherein the focus is to
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Figure 4.2: Schematic diagram of the COMPOSER model during training phase. The
source dataset (labeled) is used to train the sepsis predictor, while both source and target
(unlabeled) datasets are used to train the domain classifier. The encoder is trained to learn
representations that remove institution-specific variations whilst retaining information use-
ful for sepsis prediction.
learn representations that minimize the distributional shift between source and target do-
mains [125, 126]. In this study, we use the technique of Adversarial Domain Adaptation
(ADA) to find representations that maximize the performance of a classifier in the source
domain (where ground truth labels are available) and minimize the domain shift that exists
between source domain and application (or target) domain (where ground truth labels are
not available) [110]. Note that while the focus of introducing weighted input layer was
in improving generalizability of a model by addressing the problem of workflow and care
level-specific patterns of data missingness, the focus of ADA is to learn representations that
are robust to institution specific variability and noise. ADA training typically requires two
datasets – the source dataset which contains ground truth labels (eg. Hospital-A ICU co-
hort) and the target dataset which does not contain any ground truth labels (eg. Hospital-B
ICU cohort). The ADA component in COMPOSER model consists of three modules (three
different Feedforward Neural Networks) – encoder, sepsis predictor, and domain classifier.
During training, the encoder and the sepsis predictor are trained to maximize likelihood of
source labels (septic labels) given the source inputs. Next, to ensure that the model general-
izes well towards target domain, the encoder is trained to confuse domain classifier whose
goal is to estimate the domain of a given input sample. Figure 4.2 shows a block diagram
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of various components of ADA that are used during training of COMPOSER model.
Although we focus on using adversarial loss to minimize domain shift in this study,
several works have used other types of losses to achieve the same purpose. The Maximum
Mean Discrepancy (MMD) loss which computes the norm of the difference between two
domain means has been used in recent studies [127, 128, 129]. Other studies have focused
on proposing variants of the adversarial loss to obtain feature representations that are do-
main invariant [130, 128, 131, 132, 133]. More recently, the sliced Wasserstain discrepancy
(SWD) metric was successfully applied to perform unsupervised domain adaptation [134].
Let us consider X̄n = [Xw;n1 , X
w;n
2 , . . . .X
w;n
Tn ] to be the set of data corresponding to
a patient n whose total sequence length is Tn, note that X
w;n
t corresponds to the output
of the weighed input layer (which has been described in Section 4.4.1). Additionally
Ȳ n = [Y n1 , Y
n
2 , . . . .Y
n
Tn] corresponds to the set of septic labels (Y
n
t = {0, 1}) for the same
patient n. The ADA learning algorithm is then provided with labeled source data S drawn
from the source domain, and unlabeled target data T drawn from the target domain. The
following notations are for different components of the ADA algorithm: GE(∗; θE) is the
L-dimensional encoder with parameters θE . GS(∗; θS) is the output of sepsis predictor with
parameters θS which represents the probability of occurrence of sepsis within the next four
hours, and GDC(∗; θDC) corresponds to the output from domain classifier with parameters
θDC . The ADA loss is given by:
L(θE, θS, θDC) = LS(θE, θS) + λLA(θDC , θE) , (4.2)
where the adversarial loss (LA) and the sepsis prediction loss (LS) are given by:
LA(θE, θDC) = L
DC
A (θDC) + L
E
A(θE) , (4.3)
















Note, the adversarial loss is based on two separate classification losses, the first one (LDCA )
focuses on cross-domain classification of source and target data (and a function of θDC) and
the second one (LEA) focuses on learning features or representations that minimize cross-
domain classification (and a function of θE):















where GDC(∗; θDC)Y idomain corresponds to the probability of actual domain from which
example i was sampled from.
LEA(θE) = −LDCA (4.6)
In summary, the ADA model is trained to simultaneously minimize sepsis predictor
(or supervised) loss LS and adversarial loss LA (Equation 4.2). The adversarial loss LA is
further broken down into two components – loss corresponding to the encoder LEA and loss
corresponding to the domain classifier LDCA (Equation 4.3). The training objective for sep-
sis prediction module corresponds to minimizing the cross-entropy loss (supervised loss)
as shown in Equation 4.4. The training objective for domain classifier module corresponds
to minimizing the adversarial domain classifier loss LDCA as shown in Equation 4.5. Note
that parameters of the encoder θf are updated during minimization of the supervised loss
LS and adversarial encoder loss LEA.
Additionally, the supervised loss LS is computed only for data from source domain
(since data in target domain are unlabeled). The weighting factor λ controls the relative
strength between supervised and adversarial objectives. This procedure for training ADA
model ensures that the encoder learns representations that balance relevance of prediction
of sepsis and simultaneously maximize domain invariance.
Once ADA training has been completed, the trained encoder is used to create a cali-
bration set which forms an integral part of the conformal prediction pipeline. More details
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regarding the testing phase of COMPOSER model once ADA training has been completed
is described in the next section.
4.4.3 Detecting distribution shift using conformal prediction
Deep neural networks such as COMPOSER are trained under the assumption that distribu-
tion of data at test time will be the same as that of the training distribution. This assumption
might not hold true in the real world where data distributions could shift over time within
the same institutions, or could vary across institutions. The model still attempts to make
predictions even under the existence of such distribution shifts which can be potentially
harmful. This issue has been formulated as a problem of detecting whether a given input
data belongs to the training distribution or is out-of-distribution (OoD). There is a wide
body of research that has focused on studying the problem of detecting out-of-distribution
data [135, 136, 137, 138, 139] with a goal of providing robust predictions from an ML
model.
In this section, we use the method of conformal prediction [112, 113, 114] to develop
a pipeline that is designed to determine whether a given data sample belongs to the data
distribution from which the ADA model was trained on. A sepsis prediction is made on
the data sample only if it belongs to training distribution of the ADA model, else the data
sample is rejected and no sepsis prediction is made.
Conformal prediction has been traditionally used in classification or regression, and
can be used with any base classifier (eg. Support Vector Machine, Logistic Regression,
Neural Networks). In a regular conformal prediction framework, each possible prediction
that can be made for a given test data is evaluated based on its nonconformity score. The
non-conformity scores (for each possible prediction) with a calibration set, are then used
to compute a p-value, which are then thresholded to provide a guarantee on the error rate
[114]. We will be explaining in detail below many of the aforementioned concepts. In our
work, we modify the conformal prediction framework to help identify the presence of dis-
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Figure 4.3: Schematic diagram of the COMPOSER model being used to create cali-
bration set. Once training of COMPOSER is completed, a sub-sample of patients from
source dataset are chosen and their encoder representations are used to form the calibration
set. The calibration set is used by the conformal predictor to detect samples that are out of
sepsis predictor training distribution.
tribution shift in data, and for which we will use as input a lower dimensional representation
of the input data (the output from encoder module).
Notations: For simplicity, let us assume hi to be a P dimensional output from the en-
coder for a data sample i. Let H = [h1, h2, ..., hU ] represent the entire training set (con-
taining both septic and non-septic examples). A subset of the training set is chosen as the
calibration set, C, of size M . The calibration set can contain examples from both the septic
and non-septic classes.
A brief outline of the ‘conformal predictor’ in COMPOSER model pipeline is as fol-
lows: We are given a calibration set (c1, c2, ..., cM), where each ci ∈ RP is the output from
encoder corresponding to example i. We are then given a test example cM+1 for which: 1)
the task of conformal prediction is to predict if the test example is drawn from the same
probability distribution as that of other examples in the calibration set, and 2) if yes, the
test example cM+1 is passed onto sepsis predictor to obtain the sepsis risk score.
First, we would like to measure how likely it is that a given sequence of examples were
drawn from the same probability distribution. We will use the term p−value to measure the
typicalness of a sequence of examples wherein the p− value is computed using a function
p : Z∗ → [0, 1]. For a given input cM+1, the p− value of cM+1 denoted by p(cM+1) refers
to typicalness of the sequence (c1, c2, ...., cM , cM+1) (the sequence consists of all examples
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in calibration set plus the given test example). If p-value of a given test example is under
some very low threshold (e.g. 0.05), this would signify that the such a sequence would only
be generated at most 5% of the time by any i.i.d process, and is unlikely to belong to the
probability distribution of the calibration set. In other words, the hypothesis being tested
says “All examples in the sequence (c1, c2, ...., cM , cM+1) belong to the same probability
distribution”, and the hypothesis is rejected if p(cM+1) ≤ ε for some predetermined ε.
The p-value function can be constructed by comparing how different each example
in the sequence is from all the other examples. This is possible using the measure of
nonconformity. The measure of nonconformity intuitively corresponds to how atypical a
sequence is, and maps a bag of examples and one additional example to a scalar ηi ∈ R:
ηi = A(Hc1, ..., ci−1, ci+1, ..., cM+1I, ci) (4.7)
for each example ci, thereby measuring how different it is from other examples in the bag
Hc1, ..., ci−1, ci+1, ..., cM+1I. We use H.I to denote a bag since the order in which examples
appear in the sequence will not have any impact on the non-conformity score ηi. In this
work, the non-conformity measure is computed as follows:






The p-value of cM+1 can now be calculated as follows:
p(cM+1) =
#{i = 1, 2, 3, ...,M : ηi ≥ ηM+1}
M
(4.9)
Once p-value of the test example has been calculated, the decision rule is that a positive
prediction (test example belongs to same probability distribution as that of calibration set)
is made when p(cM+1) > ε, where ε ∈ [0, 1]. We choose ε to be 0.10 in our analysis, this
means that for i.i.d. data, we would expect with 90% confidence that the new test example
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is from the same distribution as that of calibration set. Only those test examples that have
a positive prediction (from the conformal predictor) are passed on to the sepsis predictor
to obtain a sepsis risk score. The above procedure is repeated for all samples in the testing
set, and the sepsis risk score is obtained for only those examples whose p-value is higher
than ε.
Figure 4.3 shows the schematic diagram of creating the calibration set after ADA train-
ing has been completed. Figure 4.1 shows the schematic diagram of COMPOSER model
during testing phase, wherein the conformal predictor module is used for detecting distri-
bution shift.
4.4.4 Data processing, training and hyperparameters
First, the Hospital-A ICU training set was normalized by subtracting the mean and divid-
ing by the standard deviation (both of which were computed on Hospital-A ICU training
set). Next, all remaining datasets were normalized using the mean and standard deviation
statistics computed from the Hospital-A ICU training set. For handling missing data, we
used a simple sample-and-hold approach in all the datasets.
Weighted input layer: The scaling factors αi were all initialized to 1. ADA model: The
learning rates for encoder, sepsis predictor and domain classifier were set to 0.01. Weight-
ing factor λ used in the ADA model was fixed at 1. To minimize overfitting and to improve
generalizability of the model, L1-L2 regularization was used with L2 regularization pa-
rameter set to 1e-3 for encoder and sepsis predictor, 1e-4 for domain classifier and L1
regularization parameter set to 1e-3 for encoder and sepsis predictor, 1e-4 for domain clas-
sifier. Mini-batch size for the source dataset was fixed at a total of 10000 windows (50%
septic windows, 50% non-septic windows). Mini-batch size for the target dataset was set
at 5000 windows. The encoder was made up of 1 hidden layer of dimension 40. The sepsis
predictor was made up of 1 hidden layer of dimension 25. The domain classifier was made
up of 1 hidden layer of size 25. Both sepsis predictor and domain classifier were further
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followed by a fully connected layer and a softmax layer. Conformal predictor: Threshold
ε was set at 0.10. Calibration set consisted of equal proportion of septic windows and non-
septic windows. For the chosen septic patients, 2 septic windows were sampled at random.
For the chosen non-septic patients, 2 non-septic windows were sampled at random.
We trained the COMPOSER model for a total of 500 epochs using Adam optimizer
[91], with early stopping. All hyper-parameters of the model: Number and size of layers for
encoder-sepsis predictor-domain classifier, learning rate, mini-batch size, L1 regularization
parameter, and L2 regularization parameter were optimized using Bayesian optimization
[92]. All pre-processing of data was performed using Numpy [93], with the rest of pipeline
implemented using TensorFlow [94].
4.5 Clinical workflow aware AUC (C-AUC): An improved performance evaluation
metric for sequential predictive models in healthcare
Traditionally, the Area Under the Curve (AUC) and Area under the Precision-Recall Curve
(AUCpr) have been used to measure performance of predictive models developed using
healthcare data. We use the term healthcare data to encompass both longitudinal data
(wherein data of every patient is available in the form of a sequence) and static data
(wherein a snapshot of information is available of every patient in the dataset). In this
study, we are specifically interested in evaluating performance of models on longitudi-
nal/sequential data. A primary disadvantage of using AUC/AUCpr metrics is that they
ignore the sequential nature of data and treat all data points equally without any depen-
dence on time. The clinical workflow AUC (C-AUC) is designed taking into consideration:
1) COMPOSER model is intended to be used as a clinical decision support (CDS) system,
and 2) Sequential nature of data.
First modification: A likely use-case scenario of COMPOSER model as a CDS would
be in alerting clinical staff whenever the COMPOSER score for a patient goes above a
predetermined decision threshold. Once an alert has been fired, a nurse/clinician will have
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Figure 4.4: Illustration of predictions being ignored during snooze period. The first
modification of C-AUC ignores predictions for the snooze period after predicted risk score
crosses the decision threshold. The example shown in the above figure is for a patient who
did not develop sepsis during the ICU stay.(FP = False Positive, TN = True Negative)
to evaluate the status of the patient to determine if initiation of treatment for sepsis is
required. If the patient does not require treatment, the nurse/clinician can decide to re-
evaluate after a few hours. As can be seen from this clinical workflow, once an alert has
been issued by the COMPOSER model, any predictions from the model for next few hours
will most likely be ignored by clinical staff - simply put, the model is snoozed for a few
hours after an alert has been fired. The first modification that we make to the AUC/AUCpr
metric is that any predictions after a positive prediction (onset of sepsis within then next
four hours) has been made are ignored for a fixed duration (which we call as ‘snooze
duration’). Figure 4.4 shows an example of predictions being ignored during the snooze
period.
Second modification: Sepsis is an illness that evolves progressively over time. It is diffi-
cult to exactly determine a discrete time-point as the time of onset of sepsis. Unfortunately,
this fact is not considered in the case of AUC/AUCpr where ground truth labels (in case
of four hour ahead prediction of sepsis) are defined to be non-septic until four hours prior
to tsepsis−3, and are defined to be septic between four hours prior to tsepsis−3 and tsepsis−3.
Thus, there is a discrete transition from non-septic to septic labels which can unfairly pe-
nalize a predictive model if it makes a positive prediction for onset of sepsis prior to four
hours from tsepsis−3. All those time points at which the predictive model made a posi-
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tive prediction, but fell outside the prediction horizon of four hours are counted as False
Positives. In order to minimize penalizing the algorithm for making a positive prediction
much earlier than the four hour prediction horizon, we modify the criterion for computing
False Positives (FP), True Positives (TP), False Negatives (FN) and True Negatives (TN)
as follows:
• FP: COMPOSER makes a positive prediction - M hours prior to tsepsis−3 for septic
patients or at any point of time for non-septic patients
• TP: COMPOSER makes a positive prediction - within M hours prior to tsepsis−3
• FN: COMPOSER makes a negative prediction - between four hours prior to tsepsis−3
and tsepsis−3
• TN: COMPOSER makes a negative prediction four hours prior to tsepsis−3 for septic
patients or at any point of time for non-septic patients.
We consider M (which we will call ‘positive prediction duration’) to be 12 hours in our
study, which means that we do no penalize the COMPOSER model for making a positive
prediction of onset of sepsis up to 12 hours prior to tsepsis−3. Note that we still penalize the
COMPOSER model for making a negative prediction within four hours of tsepsis−3. Figure
4.5 shows scenarios where a COMPOSER model prediction can fall into one of the four
categories described above.
Finally, the C-AUC metric takes into consideration both the first modification and sec-
ond modification described above.
4.6 Results
For training of all the models described in this section, ground truth labels (Sepsis-3 onset
times) were required only for the Hospital-A ICU cohort. No ground truth labels were used
from the Hospital-B ICU, Hospital-C ICU, Hospital-A ED and Hospital-B ED cohorts
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Figure 4.5: Illustration of categorization of predictions from a predictive model ac-
cording to the suggested second modification of C-AUC. (A) The various scenarios
where predictions could fall into one of four categories of TP, FP, TN or FN, for a septic
patient. (B) The various scenarios where predictions could fall into one of two categories
of FP or TN for a non-septic patient.
during training. The ground truth labels from all cohorts were used only to evaluate the
performance of the trained models.
4.6.1 C-AUC as a performance evaluation metric
As described in Section 4.5, C-AUC consists of two hyperparameters: snooze duration and
positive prediction duration. To study trends in C-AUC for various values of its hyper-
parameters, we performed an analysis wherein a 2 layered Feedfoward Neural Network
(FFNN) was trained on the Hospital-A ICU dataset to predict onset of sepsis within four
hours. The input to this model consisted of [Xdyamical;Xcovar] The resulting C-AUCs of
the above model (performance evaluated on the Hospital-A ICU testing set) for Snooze
durations of 0, 2, 4, 6, 8 and 12 hours; and for Positive prediction durations of 4, 6, 8
and 12 hours are shown in Table 4.1 and Table 4.2. We observed that with increasing
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snooze duration and positive prediction duration, the C-AUC increased which could be at-
tributable to the reduction of false positives. Consequently, we observed that the C-AUCpr
decreased with increase in snooze duration and positive prediction duration which could
be attributable to the reduction in total number of true positives (which leads to drop in
precision). In our study, we fixed the snooze duration at 6 hours and positive prediction
at 12 hours while computing C-AUC/C-AUCpr. Henceforth we will be reporting only the
C-AUC/C-AUCpr for the aforementioned hyperparameters.
Table 4.1: Comparison of C-AUC values for various values of snooze duration and positive
prediction duration. C-AUC values shown are for a trained FFNN model evaluated on
Hospital-A ICU testing set.
Prediction horizon before tsepsis−3 where
positive prediction not penalized
(positive prediction duration)
4 hours 6 hours 8 hours 12 hours
C-AUC (Snooze = 0 hours) 0.858 0.876 0.889 0.906
C-AUC (Snooze = 2 hours) 0.865 0.883 0.895 0.911
C-AUC (Snooze = 4 hours) 0.870 0.887 0.899 0.915
C-AUC (Snooze = 6 hours) 0.878 0.894 0.905 0.919
C-AUC (Snooze = 8 hours) 0.880 0.896 0.909 0.922
C-AUC (Snooze = 12 hours) 0.876 0.895 0.908 0.922
Table 4.2: Comparison of C-AUCpr values for various values of snooze duration and pos-
itive prediction duration. C-AUCpr values shown are for a trained FFNN model evaluated
on Hospital-A ICU testing set.
Prediction horizon before tsepsis−3 where
positive prediction not penalized
(positive prediction duration)
4 hours 6 hours 8 hours 12 hours
C-AUCpr (Snooze = 0 hours) 0.110 0.137 0.160 0.198
C-AUCpr (Snooze = 2 hours) 0.070 0.090 0.107 0.139
C-AUCpr (Snooze = 4 hours) 0.057 0.075 0.090 0.118
C-AUCpr (Snooze = 6 hours) 0.049 0.066 0.080 0.102
C-AUCpr (Snooze = 8 hours) 0.045 0.061 0.076 0.099
C-AUCpr (Snooze = 12 hours) 0.040 0.054 0.068 0.089
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4.6.2 Model performance improves with weighted input layer
Due to workflow-related variations in frequency of laboratory measurements in ICUs and
EDs, we hypothesized that when trained on ICU data and tested on ED data, a TSLM-
weighted FFNN model (in this modelXTSLM is used to only scaleXdynamical, and not used
as input feature to FFNN) would outperform a FFNN-T (input = [Xdyamical;Xcovar;XTSLM ])
which has access to the missingness data directly as an input feature (and thus likely to
overfit to the ICU workflow processes and patterns of data missingness). The data in
Table 4.3 shows that the FFNN-T trained on Hospital-A ICU data (C-AUC=0.915) ex-
hibited a significant drop in performance when applied to the Hospital-A ED population
(C-AUC=0.692) and Hospital-B ED population (C-AUC=0.772). However the TSLM-
weighted FFNN model was less likely to overfit to the ICU data and provided better per-
formance on the Hospital-A ED population (C-AUC=0.763) and Hospital-B ED popula-
tion (C-AUC=0.842) without a significant performance loss on the source Hospital-A ICU
dataset (AUC=0.923). These results suggest that XTSLM should not be used as a direct
input feature to a FFNN, thus for the remainder of our analysis we will only be using it as
part of the weighted input layer. In the case of training baseline FFNN models, the input
features were [Xdyamical;Xcovar].
The TSLM-weighted FFNN (or FFNN with weighted input layer) model was also ob-
served to perform better when trained on Hospital-A ICU data and tested on ICU data
from other hospitals. Referring to Table 4.4, we observe that the TSLM-weighted FFNN
performed slightly better compared to a FFNN (without any weighted input layer) on the
Hospital-A ICU test data (C-AUC of 0.923 vs 0.919), Hospital-B ICU test data (C-AUC
of 0.859 vs 0.842) and Hospital-C ICU test data (C-AUC of 0.871 vs 0.851). We also ob-
served that the number of False Positives (measured at 80% sensitivity) were lesser in the
case of TSLM-weighted FFNN as compared to a FFNN.
The above results indicate that a generic TSLM-weighted input layer can be used as
the first layer in a deep learning model to capture the clinical ‘intuition’ about the validity
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Table 4.3: Comparison of performance of models (FFNN-T vs FFNN with weighted input
layer) trained on Hospital-A ICU dataset and tested on ED datasets. It can be observed that
using missing data indicators (such as TSLM) as input features can lead to significant drop
in performance (in our case FFNN-T) especially when evaluated on cohorts belonging to
different level of care. However the extent of drop in performance is less significant in the
case of FFNN with weighted input layer.
FFNN-T1 FFNN
with weighted input layer2
Dataset C-AUC C-AUCpr FP# C-AUC C-AUCpr FP#
Hospital-A ICU test 0.915 0.110 10169 0.923 0.104 9878
(↓ 2.9%)
Hospital-A ED test 0.692 0.031 27524 0.763 0.033 23550
(↓ 14.4%)
Hospital-B ED test 0.772 0.068 72368 0.842 0.072 53854
(↓ 25.6%)
1 Input = [Xdyamical;Xcovar;XTSLM ]
2 XTSLM used only to scale Xdyamical, and not used as input feature to FFNN
# Number of False Positives measured at 80% sensitivity
of a piece of imputed data. We hypothesized that imposing an exponentially decaying
constraint on the scaling function with scaling factor α to be learned from the data would
provide interpretable results. Figure 4.6 shows the scaling factors that were learnt after
training a FFNN with weighted input layer on Hospital-A ICU dataset. It can be observed
that the model learnt that an imputed heart rate (α=1.9) is supposed to have a shorter half-
life than imputed lactate (α=0.078) or creatinine (α=0.75). A similar plot but for a FFNN
model trained on Hospital-A ED dataset is shown in Figure 4.9. As expected, the scaling
factors learnt by this model were lower compared to the model trained on ICU cohort.
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Table 4.4: Comparison of performance of models (FFNN vs FFNN with weighted input
layer) trained on Hospital-A ICU dataset and tested on Hospital-B and Hospital-C ICU
datasets.
FFNN1 FFNN
with weighted input layer
Dataset C-AUC C-AUCpr FP# C-AUC C-AUCpr FP#
Hospital-A ICU test 0.919 0.102 10059 0.923 0.104 9878
(↓ 1.8%)
Hospital-B ICU test 0.842 0.064 37407 0.859 0.066 34726
(↓ 7.2%)
Hospital-C ICU test 0.851 0.031 8690 0.871 0.033 7256
(↓ 16.5%)
1 Input = [Xdyamical;Xcovar]
# Number of False Positives measured at 80% sensitivity
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Figure 4.6: Illustration of the weighting scheme learnt by a FFNN with weighted in-
put layer model trained on Hospital-A ICU dataset The plots shown depict the scaling
function (varies from 0 to 1) imposed by the model for various values of Time Since Last
Measurement (varies from 0 to 24 hours) of each of the 34 dynamical variables considered
in our study.
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4.6.3 Evaluating the performance of Adversarial domain adaptation with weighted input
layer
Table 4.5: Adversarial Domain Adaptation with weighted input layer shows improved gen-
eralization performance over Adversarial Domain Adaptation. Performance of models on
the target dataset is shown in this table. Performance of same models on the source dataset
is shown in Table 4.15.
ADA1 ADA
with weighted input layer
Source/Target C-AUC C-AUCpr FP# C-AUC C-AUCpr FP#
Hospital-A ICU / Hospital-B ICU 0.860 0.065 34802 0.870 0.069 33076
(↓ 5.0%)
Hospital-A ICU / Hospital-C ICU 0.864 0.033 8252 0.879 0.030 7533
(↓ 8.7%)
Hospital-A ICU / Hospital-A ED 0.821 0.039 19855 0.847 0.039 18325
(↓ 7.7%)
Hospital-A ICU / Hospital-B ED 0.884 0.078 44589 0.893 0.083 40601
(↓ 8.9%)
1 Input = [Xdyamical;Xcovar]
# Number of False Positives measured at 80% sensitivity
The focus of employing Adversarial Domain Adaptation (ADA) was to learn data repre-
sentations that were robust to institution-specific variability and noise. We expected that for
any given pair of cohorts - source dataset (labeled) and target dataset (unlabeled) - an ADA
trained model would produce risk scores that generalize better to a target dataset without
significant loss in predictive power on the source dataset. Results in Table 4.5 show that
the ADA trained model performed better on the target datasets (when the source dataset
was Hospital-A ICU) compared to a FFNN trained on Hospital-A ICU dataset (Table 4.4).
The ADA trained model consisted of an encoder with 1 hidden layer (size of 40), sepsis
predictor with 1 hidden layer (size of 25), and a fully connected layer at the end. When the
source and target datasets had the same level of ICU care but were from different institu-
tions, the ADA trained model performed better compared to the FFNN baseline - C-AUC
of 0.860 on the Hospital-B ICU test set compared to C-AUC of 0.842. The ADA trained
model was able to perform better on the target dataset without any significant loss in perfor-
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mance on the source dataset - C-AUC of 0.913 on Hospital-A ICU test set. Similar patterns
were observed for the Hospital-A ICU/Hospital-C ICU, Hospital-A ICU/Hospital-A ED
and Hospital-A ICU/Hospital-B ED source/target combinations as well.
While the ADA trained model learned representations that are robust to institution-
specific variability and noise, the addition of a weighted input layer provided further ro-
bustness to missingness-related deleterious factors. We observed this in results tabulated in
Table 4.5. It can be observed that adding a weighted input layer improved the performance
on target datasets in comparison to ADA model alone. The ADA with weighted input layer
model performed especially well when the source and target datasets came from different
levels of care. In the case of Hospital-A ICU/Hospital-B ED (source/target) datasets, the
ADA with weighted input layer model (C-AUC=0.893) outperformed all the other baseline
models1. Similar patterns in performance were observed for other source/target dataset
combinations as well (Table 4.5). (The performance of ADA models discussed above on
the source dataset is listed in Table 4.15)
The goal of employing domain adaptation was to adapt representations learned from
the source domain to the target domain. We have tried to capture the alignment of the
representations across both the domains during ADA training in Figures 4.7 and and 4.8.
Each point on the clusters shown in the above figures is a 2D representation (projection) of
the state of a patient, constructed via first learning a 25 dimensional representation (output
of the encoder) followed by dimensionality reduction via the method of Uniform Mani-
fold Approximation and Projection (UMAP) [140]. It can be seen that the ADA method
is able to align the representations for the septic (and similarly non-septic) patients at the
end of model training. The alignment is the most distinctive in the case of ADA involving
Hospital-A ICU (source) and Hospital-B ED (target) datasets (Figure 4.8), wherein the rep-
resentations of septic patients (similarly for non-septic patients) are misaligned during the
beginning of training (this could mainly be attributed to the datasets belonging to different
1Baseline models include FFNN, FFNN with weighted input layer, ADA
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levels of care) while at the end of training, the representations are aligned (but with some
shift) in both the domains.
4.6.4 Evaluating the performance of COMPOSER model
Thus far we have shown that an ADA trained model with weighted input layer generalizes
well to a target dataset, thereby learning representations that are both robust to institution-
specific variability and level of care specific data missingness patterns. Although the goal
of the ADA framework is to minimize distributional shifts that might potentially exist be-
tween datasets, it still lacks the ability to quantitatively determine the extent to which dis-
tributional shifts can be tolerated. By using a conformal prediction framework based on the
above learned representations, we can explicitly determine the extent of distribution shifts
that are tolerable to make a trustable prediction of sepsis risk score. The resulting pipeline
consisting of the ADA trained model, weighted input layer and conformal predictor makes
up the COMPOSER model. In this section, we consider scenarios where the source dataset
is Hospital-A ICU cohort and study the performance of COMPOSER model on various
target datasets - Hospital-B ICU/Hospital-C ICU/ Hospital-A ED/Hospital-B ED. The per-
formance of COMPOSER model for the above four scenarios has been tabulated in Table
4.6, Table 4.7, Table 4.8 and Table 4.9.
For the conformal predictor, we chose ε to be 0.10 in our analysis which means that
we could expect predictions on samples classified to be ‘in-distribution’ to be 90% correct.
We would like to reiterate that first the ADA (with weighted input layer) model was trained
on the source and target datasets, afterwhich a sub-sample of the source dataset was used
to create the calibration set. This calibration set was used by the conformal predictor to
determine whether to accept or reject a test sample for prediction of onset of sepsis. In our
analysis, we found that the COMPOSER model performed better compared to a baseline C-
FFNN2 (FFNN with conformal predictor). The COMPOSER model trained using Hospital-
2C-FFNN: FFNN with conformal predictor: This was a 2 layer FFNN, wherein representations from the
second layer of the network were used as input to the conformal predictor
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Table 4.6: Performance of COMPOSER model trained using Hospital-A (source) and
Hospital-B (target) ICU datasets. The scaling factors learnt by this COMPOSER model
are shown in Figure 4.10. Also shown is the performance of a FFNN trained on Hospital-A
ICU dataset and tested on Hospital-A and Hospital-B ICU datasets.
C-FFNN1 COMPOSER
(Hospital-A ICU/Hospital-B ICU)
Dataset C-AUC FP# RW∗ C-AUC FP# RW∗
Hospital-A ICU test 0.925 9437 16102 (11.3%) 0.924 8347 15966 (11.2%)
(source) (15912/190) (↓ 11.6%) (15791/175)
Hospital-B ICU test 0.869 32720 42649 (12.1%) 0.882 31558 42919 (12.2%)
(target) (42267/382) (↓ 3.6%) (42559/360)
1 Input = [Xdyamical;Xcovar]
# Number of False Positives measured at 80% sensitivity
* Number of Rejected Windows (%) using conformal prediction. Also shown is - (number of rejected non-
septic windows/rejected septic windows)
A ICU as source data and Hospital-B ICU as the target data achieved a C-AUC of 0.882 on
the Hospital-B ICU test set while still maintaining comparable performance on the source
dataset (C-AUC=0.924). The rejection rate was found to be 12.2% and 11.2% for the
Hospital-A and Hospital-B ICU datasets respectively. It can be observed that a majority of
the rejected samples were from the non-septic class. Additionally, the scaling factors learnt
by this COMPOSER model are shown in Figure 4.10. A visualization of the alignment
of representations of Hospital-A ICU and Hospital-B ICU datasets after ADA training is






































































































































































































































































































































































































Table 4.7: Performance of COMPOSER model trained using Hospital-A (source) and
Hospital-C (target) ICU datasets. Additionally, the scaling factors learnt by this COM-
POSER model are shown in Figure 4.11. Also shown is the performance of a FFNN trained
on Hospital-A ICU dataset and tested on Hospital-A and Hospital-C ICU datasets.
C-FFNN1 COMPOSER
(Hospital-A ICU/Hospital-C ICU)
Source/Target C-AUC FP# RW∗ C-AUC FP# RW∗
Hospital-A ICU test 0.925 9437 16102 (11.3%) 0.922 9572 15304 (10.7%)
(source) (15912/190) (↑ 1.4%) (15125/179)
Hospital-C ICU test 0.856 8072 9895 (11.6%) 0.885 6743 10651 (12.5%)
(target) (10557/53) (↓ 16.5%) (10604/47)
1 Input = [Xdyamical;Xcovar]
# Number of False Positives measured at 80% sensitivity
* Number of Rejected Windows (%) using conformal prediction. Also shown is - (number of rejected
non-septic windows/rejected septic windows)
A COMPOSER model trained using Hospital-A ICU data as the source and Hospital-C
ICU as the target achieved a C-AUC of 0.885 on the Hospital-C ICU test set which was
0.031 points improvement in C-AUC compared to C-FFNN. The rejection rate was found
to be 12.2% for the Hospital-C ICU test set. Additionally, the scaling factors learnt by this
COMPOSER model are shown in Figure 4.11.
The performance of COMPOSER remained consistent when the source and target datasets
were from different levels of care. A COMPOSER model trained using Hospital-A ICU
data as the source and Hospital-A ED as the target achieved a C-AUC of 0.851 on the
Hospital-A ED test set compared to C-AUC 0.830 obtained by the C-FFNN. The rejection
rate was found to be 8.4% for the Hospital-A ED test set. Additionally, the scaling factors
learnt by this COMPOSER model are shown in Figure 4.12.
Finally, a COMPOSER model trained using Hospital-A ICU data as the source and
Hospital-B ED as the target achieved a C-AUC of 0.899 on the Hospital-B ED test set
compared to C-AUC 0.890 obtained by the C-FFNN. The rejection rate was found to be
7.4% for the Hospital-B ED test set. Overall, it was observed that for ε of 0.10, the rejection
rate was around 5-10% across all the cohorts. Additionally, the scaling factors learnt by
this COMPOSER model are shown in Figure 4.13. A visualization of the alignment of
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Table 4.8: Performance of COMPOSER model trained using Hospital-A ICU (source)
and Hospital-A (target) ED datasets. Additionally, the scaling factors learnt by this COM-
POSER model are shown in Figure 4.12. Also shown is the performance of a FFNN trained
on Hospital-A ICU dataset and tested on Hospital-A ICU and Hospital-A ED datasets.
C-FFNN1 COMPOSER
(Hospital-A ICU/Hospital-A ED)
C-AUC FP# RW∗ C-AUC FP# RW∗
Hospital-A ICU test 0.925 9437 16102 (11.3%) 0.925 9733 14896 (10.5%)
(source) (15912/190) (↑ 3.1%) (14727/169)
Hospital-A ED test 0.830 19882 14093 (9.3%) 0.851 17868 12749 (8.4%)
(target) (13972/121) (↓ 10.3%) (12575/174)
1 Input = [Xdyamical;Xcovar]
# Number of False Positives measured at 80% sensitivity
* Number of Rejected Windows (%) using conformal prediction. Also shown is - (number of rejected non-
septic windows/rejected septic windows)
representations of Hospital-A ICU and Hospital-B ED datasets after ADA training is shown
in Figure 4.8.
Table 4.9: Performance of COMPOSER model trained using Hospital-A ICU (source)
and Hospital-B (target) ED datasets. Additionally, the scaling factors learnt by this COM-
POSER model are shown in Figure 4.13. Also shown is the performance of a FFNN trained
on Hospital-A ICU dataset and tested on Hospital-A ICU and Hospital-B ED datasets.
C-FFNN1 COMPOSER
(Hospital-A ICU/Hospital-B ED)
C-AUC FP# RW∗ C-AUC FP# RW∗
Hospital-A ICU test 0.925 9437 16102 (11.3%) 0.927 9689 15420 (10.8%)
(source) (15912/190) (↑ 3.1%) (15248/173)
Hospital-B ED test 0.890 41106 23062 (5.9%) 0.899 39619 28774 (7.4%)
(target) (22381/681) (↓ 3.6%) (28145/629)
1 Input = [Xdyamical;Xcovar]
# Number of False Positives measured at 80% sensitivity
* Number of Rejected Windows (%) using conformal prediction. Also shown is - (number of rejected








































































































































































































































































































































































4.6.5 Validation of COMPOSER predictions with chart reviewed data
The guidelines recommended by Third International Consensus Definitions for Sepsis (Sepsis-
3) has been used by the authors of this study to obtain labels for onset of sepsis (tsepsis−3) in
all the five patient cohorts. As mentioned in Section 1.2, there are numerous other criteria
for sepsis that are still in wide use. One has to be cognizant of two points when employing
these rule based criteria: 1) they are at best an approximate attempt to identify the onset
time of this complex disease, and 2) they do not account for any confounding factors that
might be contributing to symptoms manifesting as sepsis thereby leading to incorrect la-
belling of sepsis. In order to obtain a gold standard for onset of sepsis, one will have to
manually go through the EHR record (with access to all notes from attending clinical staff,
laboratory orders, culture orders etc.) of a patient and verify that there are no other con-
founding factors (eg. presence of other critical illness such as cancer) that are contributing
to a patient displaying symptoms for sepsis.
As part of a Quality Improvement (QI) program at Hospital-A Health system, a quar-
terly review is conducted to evaluate the rate of compliance with SEP-1 care bundle [19].
The SEP-1 bundle advocates for obtaining blood cultures, administering broad spectrum
antibiotics, measuring lactate, and starting appropriate fluid resuscitation if clinically indi-
cated, all within 3 hours of clinical recognition of sepsis. A random sample of 60 patients
who are admitted (to the two hospitals within the Hospital-A health system) in the quarter
of interest are chosen, and are manually reviewed by the quality improvement team (con-
sisting of clinical staff and hospital administrators) to identify the onset of sepsis (according
to CMS guidelines) and if SEP-1 bundle compliance was met within three hours of onset
of sepsis. We obtained access to this higher quality labels for the period between January
1st 2016 and March 28th 2019. Excluding all the transfer patients3 and all patients whose
onset time of sepsis was within the first hour of admission to ED/ICU, the cohort consisted
3Patients who were received from an inpatient, outpatient or emergency/observation department of an
outside hospital or from an ambulatory surgery center
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of 667 patients out of whom 524 were tagged septic (according to Sepsis CMS guidelines).
Out of the 667 patients, 404 patients were present in our combined Hospital-A ICU and ED
cohorts. The reduction in the number of patients was due to restricting the patients to only
ICU and ED admits. We will be using this cohort (Hospital-A-QI cohort) of 404 patients
for our analysis in this section. Out of the 404 patients in the Hospital-A-QI cohort, 311
patients were tagged septic (Sepsis CMS guidelines have been used to identify onset time
of sepsis in Hospital-A-QI cohort).
Table 4.10: Evaluating accuracy of various rule based methods for identifying onset time
of sepsis versus chart reviewed data. Also shown is the accuracy of predictions from COM-
POSER model evaluated against chart reviewed data. For results shown in this table, the
COMPOSER model was trained on the combined Hospital-A ICU and ED cohorts. A
description of each of the sepsis criteria used for this analysis is available in Table 4.12.
Sensitivity Specificity PPV/Precision F1 score
Sepsis-2 [17] 0.778 0.355 0.801 0.790
Sepsis-3 [1] 0.559 0.688 0.857 0.677
Sepsis-CDC [18] 0.643 0.774 0.905 0.752
Sepsis-CMS@ [19, 141] 0.707 0.774 0.913 0.797
Sepsis-CMS-Causal$ 0.733 0.817 0.931 0.820
Any of definitions 0.875 0.258 0.798 0.834
COMPOSER∗ 0.852 0.548 0.863 0.858
@ Clinical suspicion of infection is determined using the same criterion specified in the
Sepsis-3 guidelines (Ordering of Antibiotics and Cultures within a certain timeperiod).
We do not look at documentation of suspected infection in EHR notes
$ This is a causal implementation of the Sepsis-CMS criterion. Conditions for Suspicion
of infection, SIRS and organ should be satisfied within the last six hours.
* Threshold for COMPOSER prediction set at 85% sensitivity level
We evaluated the accuracy of Sepsis-3 guidelines by comparing the outcomes on pa-
tients from applying the Sepsis-3 criterion against the outcomes in the Hospital-A-QI co-
hort. We evaluated the outcomes on the patient level i.e. evaluating whether a patient
was tagged septic or not, with the outcomes in Hospital-A-QI cohort considered as ground
truth labels and outcomes using the sepsis-3 guidelines as predicted labels. The sensitivity,
specificity, Positive predictive value (PPV) and F1 score for were computed based on the
following measures:
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• True Positives: Patient tagged septic in Hospital-A-QI cohort and the onset time of
sepsis according to Sepsis-3 guidelines was within 12 hours prior to onset time of
sepsis (as determined in Hospital-A-QI cohort) or three hours after.
• False Negatives: Patient tagged septic in Hospital-A-QI cohort and patient tagged
non-septic by Sepsis-3 guidelines.
• True Negatives: Patient tagged non-septic in Hospital-A-QI cohort and patient tagged
non-septic by Sepsis-3 guidelines.
• False Positives: Patient tagged non-septic in Hospital-A-QI cohort and patient tagged
septic by Sepsis-3 guidelines.
The results obtained by applying Sepsis-3 guidelines on the Hospital-A-QI cohort is
shown in Table 4.10. The F1 score for applying the sepsis-3 guidelines was found to be
0.677. The Sepsis-3 criterion had a higher F1 score when evaluated on only ICU admissions
in the Hospital-A-QI cohort (F1 score=0.800). The lag between onset time of sepsis in
the Hospital-A-QI cohort and the onset time identified by Sepsis-3 criterion was found to
be 1.18 [0.24, 2.88] hours (Median [Interquartile range]). This means that the Sepsis-3
criterion was satisfied on an average 1.18 hours earlier to the criterion used in Hospital-A-
QI cohort. Considering these statistics, we would expect that a predictive model such as
COMPOSER trained to predict Sepsis-3 labels four hours in advance would have a higher
F1-score on the Hospital-A-QI cohort.
For evaluating the performance of COMPOSER model on the Hospital-A-QI cohort,
it was trained (using Sepsis-3 labels) using Hospital-A ICU cohort as the source dataset
and Hospital-A ED cohort as the target dataset, with the exclusion of patients who were
present in the Hospital-A-QI cohort. This made sure that the COMPOSER model had no
prior access to patients present in the Hospital-A-QI cohort. The trained COMPOSER
model was then applied sequentially on every patient in the Hospital-A-QI cohort to obtain
prediction of onset of sepsis for every hour that the patient was in the ED or ICU. For all
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Table 4.11: Comparison of COMPOSER model performance on the Hospital-A-QI cohort
for various sensitivity levels threshold levels.
Sensitivity Specificity PPV/Precision F1 score
0.502 0.882 0.934 0.653
0.598 0.796 0.907 0.721
0.698 0.731 0.897 0.785
0.797 0.581 0.864 0.829
0.852 0.548 0.863 0.858
0.897 0.430 0.840 0.868
septic patients in the Hospital-A-QI cohort, we considered a COMPOSER prediction to be
septic if the predicted risk score crossed a decision threshold within 12 hours prior to onset
time of sepsis (as determined in Hospital-A-QI cohort) or three hours after. The resulting
performance of the COMPOSER model is shown in Table 4.11. The results shown in
Table 4.11 are based on thresholds that were chosen at different sensitivity levels. It can
be seen that the COMPOSER model achieved highest F1 score (0.858) for threshold level
corresponding to 85% sensitivity.
We have additionally implemented some of the other sepsis guidelines that are in wide
use currently and have shown their performance in matching with the labels of Hospital-A-
QI cohort in Table 4.10.
4.7 Discussion
In this work, a deep learning model (COMPOSER) was used to learn representations that
minimize variations in clinical workflow patterns in data across levels-of-care and different
healthcare systems. COMPOSER was trained to accurately predict the likelihood of sep-
sis in patients admitted to the ED or ICU upto four hours in advance. The COMPOSER
model consisted of three components: 1) a weighted input layer (with the weighting factors
learned from data) that was designed to handle missing data and variations in data measure-
ment frequency, 2) an Adversarial Domain Adaptation procedure to learn representations
that minimize healthcare system specific variations, and 3) a conformal predictor that estab-
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lished the level of data distribution shift that was tolerable to make a risk score prediction.
A key advantage of the COMPOSER model was in its ability to adapt (or generalize) to
new unlabeled target patient population; therefore, gold-standard labels which are often
expensive to obtain are not required to deploy the model at a new center. COMPOSER was
developed to predict tsepsis−3 (Sepsis-3 criterion) in this study. Additionally, we introduced
a new performance evaluation metric, C-AUC, that was designed taking into consideration
the CDS requirements of a predictive model such as COMPOSER and the sequential nature
of healthcare data.
The generalizability of COMPOSER was shown on data from over 480,000 patients
comprising of ICU and ED cohorts from Hospital-A, ICU cohort from Hospital-C, and ICU
and ED cohorts from Hospital-B. We observed that the COMPOSER model achieved a C-
AUC of around 0.92 on the source Hospital-A ICU testing set, whilst achieving C-AUCs
of around 0.88 on the two target ICU cohorts (Hospital-C and Hospital-B ICU testing
sets) separately for four hour ahead prediction of tsepsis−3. Similarly, the performance
of COMPOSER was consistent when the target cohorts were from different level of care
compared to the source cohort - C-AUC of 0.851 on Hospital-A ED testing set and C-
AUC of 0.899 on the Hospital-B ED testing set when the source cohort was Hospital-A
ICU. Finally, there was high concordance between the sepsis risk score predictions from
COMPOSER and sepsis onset labels obtained through manual chart review.
The proposed weighted input layer showed improvement in performances by around 2
points in C-AUC on external testing cohorts over a baseline FFNN without the weighted
input layer. The improvement was significant when a model trained on ICU cohort was
tested on ED cohorts (Table 4.3). While the weighted input layer was designed to scale the
value of a feature (with the scaling factor learned during training) based on the time since
it was last measured (TSLM), a number of other studies have approached the problem of
imputing missing data by concatenating a missing value indicator to the inferred values for
missing labs [142, 143, 108], with the hope that complex models such as neural networks
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can learn arbitrary features of the missing data that are helpful for downstream prediction
tasks. Notably, a recent study [144] proposed a constrained network architecture to learn
separate representations for masking (indicating observed versus missing/imputed values)
and time interval (encapsulating the input observation patterns) related information in time
series with missing data. While all these single-center studies report performance improve-
ment with the incorporation of missing data indicators, there are little to no studies of the
ability of such models to generalize well to new patient populations. In our work, we have
shown the generalizability of using a weighted input layer on five different cohorts from
three different hospital systems and across two different levels of care.
The Adversarial Domain Adaptation (ADA) technique used in this study allowed for
successfully adapting representations learned from a source dataset (where labels were
available) to a target dataset (where labels were not available, a likely scenario would in-
clude data from a new institution). The ADA training procedure was shown to perform
well in scenarios where target datasets were from a different level of care compared to the
source dataset eg. Hospital-A ICU (source) and Hospital-B ED (target). In literature, a ma-
jority of the clinical ML models that have been validated across different health systems are
either trained from scratch or are fine-tuned (visa transfer learning) on every new patient
cohort [24, 25, 50], or when applied out-of-the box often exhibit significant degradation in
performance [51]. The advantage of employing a training procedure such as ADA was to
transfer knowledge learned from the source dataset whilst overcoming the requirement of
gold-standard labels on a target population.
The representations (output from the encoder) obtained by the combination of ADA
and weighted input layer are robust to care-level and institution-specific patterns in data
missingness. In order to establish the extent to which shifts in distribution of data was
tolerable to make a prediction, the method of conformal prediction was employed on these
representations. The rejection rate was found to be around 5-10% across all the cohorts,
for ε of 0.10. Some of the advantages that arise from establishing a metric to quantify the
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extent of tolerable distributional shift include: 1) it potentially satisfies a key requirement
of FDA regulations on SaMD, by establishing the ‘conditions for use’ of the COMPOSER
score, and 2) when deployed as a real-time system, one could track the average rejection
rates over time and identify any potential drifts in data distribution.
In general, statistical evaluation methods (such as the AUC) have a limited applicability
when evaluating the clinical utility of such algorithms, although they can provide quanti-
tative metrics for the comparison of various algorithms. In practice, performance metrics
are only meaningful when coupled with appropriate clinical protocols that describe the
course of action in response to the associated risk alerts. The clinical workflow aware AUC
(C-AUC) metric proposed in this study takes into account simple clinical actions such as
‘snoozing’ the alarm for X hours if the patient did not meet the clinical threshold to initiate
therapy, not penalizing the algorithm for making a positive prediction earlier than the pre-
diction horizon. By taking into consideration the above factors, the C-AUC metric brings
us one step closer to evaluating the actual performance of COMPOSER when deployed as
a CDS system.
In this chapter, we have shown that by carefully taking into consideration the processes
that are involved in generation/collection of healthcare data and the likely workflow pro-
cesses of CDS systems, we can develop predictive models that can generalize well to new
target populations. Although the COMPOSER model was trained to predict the onset of
sepsis in this study, the techniques used to construct COMPOSER can be utilized for build-
ing predictive models for other types of physiological decompensation such as AKI.
4.8 Appendix
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Table 4.12: Description of defined time points utilized in this chapter.
Time point Criteria
tsuspicion Clinical suspicion of infection identified as the earlier timestamp
of antibiotics and blood cultures within a specified duration. (If
antibiotics were given first, the cultures must have been obtained
within 24 hours. If cultures were obtained first, then antibiotic
must have been subsequently ordered within 72 hours)
tSOFA The occurrence of end organ damage as identified by a two-point
deterioration in SOFA score within a 6-hour period
tsepsis−3 The onset time of sepsis-3 is marked when both tsuspicion and
tSOFA have happened within close proximity to each other.
Specifically, tSOFA must occur 24 hours before tsuspicion or up to
12 hours after the tsuspicion (tSOFA + 24 hours> tsuspicion > tSOFA
- 12 hours). The earlier of the tSOFA or tsuspicion was assigned to
tsepsis−3.
teSOFA The occurrence of end organ damage as identified by one point or
higher eSOFA score within a 6-hour period [145]
tsepsis−CDC The onset time of tsepsis−CDC is marked when both tsuspicion
and teSOFA have happened within close proximity to each other.
Specifically, teSOFA must occur 24 hours before tsuspicion or up
to 12 hours after the tsuspicion (teSOFA + 24 hours > tsuspicion >
teSOFA - 12 hours). The earlier of the teSOFA or tsuspicion was
assigned to tsepsis−CDC
tcmsSOFA The occurrence of end organ damage as specified in the SEP-1
CMS manual [141]
tsepsis−CMS All three of the signs of severe sepsis should occur within a 6-
hour window: 1) tsuspicion, 2) ≥ 2 Systemic Inflammatory Re-
sponse Syndrome criteria, and 3) tcmsSOFA. The onset time of
tsepsis−CMS is the time at which the last sign of severe sepsis
within that 6-hour window is noted.
tsuspicion−Causal Clinical suspicion of infection identified as the earlier times-
tamp of antibiotics and blood cultures within a specified duration.
(Both antibiotics and cultures should have been ordered in the
previous 6 hours)
tsepsis−CMS−Causal All three of the signs of severe sepsis should occur within a 6-
hour window: 1) tsuspicion−Causal, 2) ≥ 2 Systemic Inflammatory
Response Syndrome criteria, and 3) tcmsSOFA. The onset time
of tsepsis−CMS is the time at which the last sign of severe sepsis
within that 6-hour window is noted.
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Table 4.13: Comparison of performance of models (FFNN vs FFNN with weighted input
layer) trained on Hospital-A ICU dataset. The performance of the models on the Hospital-
A ICU, Hospital-C ICU and Hospital-B ICU training sets are shown.
FFNN1 FFNN
with weighted input layer
Dataset C-AUC C-AUCpr C-AUC C-AUCpr
Hospital-A ICU train 0.927 0.107 0.927 0.111
Hospital-B ICU train 0.868 0.069 0.876 0.071
Hospital-C ICU train 0.843 0.028 0.861 0.031
1 Input = [Xdyamical;Xcovar]
Table 4.14: Performance of baseline FFNN1 model (trained on Hospital-A ICU) on
Hospital-A and Hospital-B ED datasets
Dataset C-AUC C-AUCpr
Hospital-A ICU test 0.919 0.102
Hospital-A ED test 0.829 0.037
Hospital-B ED test 0.881 0.072
1 Input = [Xdyamical;Xcovar]
Table 4.15: ADA with weighted input layer shows improved generalization performance
over ADA. Performance of models on the source dataset is shown in this table. Performance
of same models on the target dataset is shown in Table 4.5.
ADA1 ADA
with weighted input layer
Source/Target C-AUC C-AUCpr C-AUC C-AUCpr
Hospital-A ICU / Hospital-B ICU 0.913 0.097 0.918 0.103
Hospital-A ICU / Hospital-C ICU 0.916 0.102 0.915 0.101
Hospital-A ICU / Hospital-A ED 0.913 0.102 0.921 0.103
Hospital-A ICU / Hospital-B ED 0.920 0.101 0.921 0.104
1 Input = [Xdyamical;Xcovar]
110
Table 4.16: List of clinical variables used in this study.
Variable Measurement Unit





Mean Arterial Pressure mmHg
Diastolic BP mmHg
Respiration rate breaths per minute
End tidal CO2 mmHg
Laboratory values (Dynamical Features)
Excess bicarbonate mmol/L
Bicarbonate mmol/L
Fraction of inspired Oxygen %
pH -
Partial pressure of CO2 from arterial blood
Oxygen saturation from arterial blood %
Aspartate transaminase IU/L















Partial Thromboplastin Time seconds






Units Medical/Surgical ICU unit
Hours between hospital admit and ICU admit hours
ICU length of stay hours
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Figure 4.9: Illustration of the weighting scheme learnt by a FFNN with weighted in-
put layer model trained on Hospital-A ED dataset The plots shown depict the scaling
function (varies from 0 to 1) imposed by the model for various values of Time Since Last
Measurement (varies from 0 to 24 hours) of each of the 34 dynamical variables considered
in our study.
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Figure 4.10: Illustration of the weighting scheme learnt by a COMPOSER model
trained on Hospital-A ICU (source dataset) and Hospital-B ICU (target dataset) co-
horts. The plots shown depict the scaling function (varies from 0 to 1) imposed by the
model for various values of Time Since Last Measurement (varies from 0 to 24 hours) of
each of the 34 dynamical variables considered in our study.
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Figure 4.11: Illustration of the weighting scheme learnt by a COMPOSER model
trained on Hospital-A ICU (source dataset) and Hospital-C ICU (target dataset) co-
horts. The plots shown depict the scaling function (varies from 0 to 1) imposed by the
model for various values of Time Since Last Measurement (varies from 0 to 24 hours) of
each of the 34 dynamical variables considered in our study.
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Figure 4.12: Illustration of the weighting scheme learnt by a COMPOSER model
trained on Hospital-A ICU (source dataset) and Hospital-A ED (target dataset) co-
horts. The plots shown depict the scaling function (varies from 0 to 1) imposed by the
model for various values of Time Since Last Measurement (varies from 0 to 24 hours) of
each of the 34 dynamical variables considered in our study.
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Figure 4.13: Illustration of the weighting scheme learnt by a COMPOSER model
trained on Hospital-A ICU (source dataset) and Hospital-B ED (target dataset) co-
horts. The plots shown depict the scaling function (varies from 0 to 1) imposed by the
model for various values of Time Since Last Measurement (varies from 0 to 24 hours) of











































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































CONCLUSION AND FUTURE WORK
Developing predictive analytic models that can predict early onset of physiological decom-
pensation may aid clinicians in initiating early treatment and can potentially save lives.
The work presented in this thesis constitutes a step in bridging the gap between predictive
models developed using retrospective data and the clinical utilization of such models, with
the goal of improved patient monitoring and clinical decision support.
5.1 Summary of contributions
In Chapter 2, we focused on developing a technique to capture interactions between multi-
scale HR and BP time series - through quantification of the structure of their corresponding
network representations - for early prediction of sepsis. It was shown that features derived
from a multiscale HR and MAP time series network provide approximately 20% improve-
ment over traditional indices of heart rate entropy in the AUROC for four-hour advance
prediction of sepsis. This improvement was attributable to the information embedded in
the higher order interaction of HR and MAP time series, as well as to the proposed novel
approach to network construction, utilizing adaptive partitioning of the state-space to de-
fine a set of discrete states. The resulting algorithm was quick to implement, and readily
extensible to multiscale analysis of the time series networks.
Chapter 3 discussed DeepAISE (Deep Artificial Intelligence Sepsis Expert), a recur-
rent neural survival model for the early prediction of sepsis. DeepAISE utilized: 1) a class
of deep learning models called Recurrent neural networks (RNNs), and 2) the Weibull Cox
survival model on a combination of low-resolution EHR data and high resolution vital signs
time series data for early prediction of onset of sepsis. This architecture was chosen in the
context of predicting sepsis onset time as a time-to-event analysis and considering that
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temporal changes in patients’ physiology are important for prediction of sepsis. DeepAISE
was an externally evaluated sepsis model developed using over 25,000 patient admissions
to the Intensive Care Units (ICUs) at two Emory University hospitals, over 18,000 ICU
admissions to the UC San Diego Health system and over 40,000 ICU admissions from the
Medical Information Mart for Intensive Care-III (MIMIC-III) ICU database.
Furthermore, we focused on making DeepAISE predictions interpretable by utilizing
relevance scores (inspired from the concept of saliency maps for convolutional neural net-
works) to determine the top contributing factors of the output risk score at every point of
time during an ICU stay. Additionally, the hidden representations learned by the recur-
rent neural network were used to construct a lower dimensional view of a patients’ tra-
jectory. These two attributes allow the bedside clinician to identify pathologic deviations
from expected physiology early and in real-time throughout the duration of patients’ hos-
pital admission. Moreover, we showed that the top causes could be broken down into two
categories of positively and negatively contributing factors to the risk score. Notably, this
analysis has shed insight on the input features contributing significantly to the sensitivity
(positive contributors) and specificity (negative contributors) of DeepAISE.
With the goal of developing generalizable predictive models, Chapter 4 introduced
the COMPOSER model. We first proposed a weighted input layer that was designed to
handle missing data and variations in data measurement frequency across various levels
of care (Emergency Departments, ICUs, Wards etc.) and across different institutions. We
then utilized the technique of Adversarial Domain adaptation to learn representations that
minimize healthcare system specific variations. A key importance of utilizing ADA training
procedure was the design of a predictive model that could adapt to new unlabeled target
patient population; therefore, gold-standard labels which are often expensive to obtain,
were not required to deploy the model at a new center. We finally utilized the framework of
conformal prediction for establishing the ’conditions for use’ of the COMPOSER model.
This enabled us explicitly determine at what level of data covariance shift we could still
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trust a clinical risk score.
We showed the generalizability of COMPOSER model by utilizing data from over
480,000 patients collected between 2016-2019 from three different academic medical cen-
ters in the US, including data from Emergency Departments (EDs), Intensive Care Units
(ICUs), and general wards. Additionally, the COMPOSER model predictions were vali-
dated against a cohort of 400 patients who were manually chart reviewed to determine the
onset of sepsis.
5.2 Suggestions for future work
In this section, we discuss some of the potential future directions of the works presented in
this thesis:
While we present a model that captured multiscale interactions in physiological time se-
ries data in Chapter 2, we hypothesize that the deep learning models discussed in Chapters
3 and 4 (DeepAISE and COMPOSER) can benefit from: 1) additional input features that
capture multiscale interactions, and 2) designing hierarchical neural network architectures.
In this thesis, we have specifically focused on utilizing structured EHR data (such as lab
values, vital signs etc.) to build predictive models. However, EHRs additionally consists
of unstructured clinical notes, which contain information about patients that could provide
more detailed or complementary information in addition to structured data [146]. Incorpo-
rating clinical notes into the models proposed in this thesis could improve their prediction
performance.
In Chapter 3, we have studied the validity of using relevance scores to identify the most
relevant features (that are locally interpretable) contributing to the outcome risk score.
In addition to relevance scores, other local interpretability techniques such as Local In-
terpretable Model-agnostic Explanations (LIME) [147] and Shapley Value Explanations
[148] could be used to identify the most relevant features and consensus features identi-
fied amongst all the three techniques could be shown to the bedside clinician. A major
122
barrier in the progress of treatment therapies for sepsis is the overly broad definition of
the syndrome, consisting of a wide array of clinical and biological features. Different
combinations of these features could naturally cluster into phenotypes that may respond
differently to treatments. While previous works have focused on deriving such phenotypes
based on input features alone [149], we hypothesize that the representation learning and
explainability-related features proposed in this thesis could further aid in discovering more
meaningful phenotypes and likely provide promising directions for future sepsis research.
The technique of Adversarial Domain Adaptation involves adapting representations
from a source dataset (labeled) to a target dataset (unlabeled). In our work, the target
dataset typically consists of real-world data from a target population (eg. ICU population
in a different hospital). In scenarios where access to large data from a target population
is limited, one could train a generative model on data from the target population, and use
the institution-specific generative model to augment real-world data for domain adapta-
tion. Additionally, the sepsis predictor and the encoder modules in the COMPOSER model
could be made more expressive by utilizing the technique of continual learning. For exam-
ple, an encoder that was first trained on Hospital A ICU (source dataset) and Hospital B
ICU (target dataset), could then be used as the initial starting point for performing domain
adaptation on a new target dataset (Hospital C ICU) rather than initializing the encoder
with random parameters for the new task. However, it has been observed that deep learning
models trained using continual learning approaches are often susceptible to catastrophic
forgetting and care must be taken to overcome catastrophic forgetting in such scenarios
[150].
Our experiments have shown that false-positive cases are often attributable to patients
who are very sick due to other types of decompensation [25]. Our preliminary data shows
that incorporation of a mortality risk score as a feature can help reduce false alarms. Sim-
ilarly, we hypothesize that utilizing other EHR-based risk scores such as those for AKI,
Respiratory arrest, as input features in a sepsis prediction model can reduce false alarms.
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Similarly, better modeling of co-morbid conditions and chronic illnesses and the associ-
ated treatments (such as chemotherapy) would be an effective approach to further reducing
false positives. Ultimately, the three pillars of sepsis identification include pathogen de-
tection and profiling, quantification of dysregulated immune system response to infection,
and assessment of physiological decompensation/deterioration [2]. As such, incorporation
of biomarkers for pathogen discovery, and host immune system response will improve the
specificity of sepsis identification [151, 152, 153]. However, there is no effective method
to determine the timing of ordering of biomarkers. The traditional biomarker-based scores
can benefit from EHR-based continuous risk assessment models (such as COMPOSER) by
providing guidance for timing of ordering of such biomarkers, which leads to improved
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[84] E. H. Shortliffe and M. J. Sepúlveda, “Clinical decision support in the era of ar-
tificial intelligence,” The Journal of the American Medical Association, vol. 320,
no. 21, pp. 2199–2200, 2018.
132
[85] J. Norrie, “The challenge of implementing ai models in the icu,” The Lancet Respi-
ratory Medicine, vol. 6, no. 12, pp. 886–888, 2018.
[86] C. L. Ventola, “The antibiotic resistance crisis: Part 1: Causes and threats,” Phar-
macy and Therapeutics, vol. 40, no. 4, p. 277, 2015.
[87] A. E. Johnson, T. J. Pollard, L. Shen, H. L. Li-wei, M. Feng, M. Ghassemi, B.
Moody, P. Szolovits, L. A. Celi, and R. G. Mark, “Mimic-iii, a freely accessible
critical care database,” Scientific Data, vol. 3, p. 160 035, 2016.
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